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1 Summary
Self / non-self discrimination is one of the main features of the immune system of higher
animals. While encounter with self-molecules should induce tolerance, the appropriate recog-
nition of non-self antigen triggers immune reactions. A careful balance between induction of
immunity and tolerance is especially important at body surfaces such as the intestinal tract,
where also foreign, commensal-derived antigens must be tolerated. Dendritic cells (DCs) have
key roles in this important equilibrium as they can induce both, immunity and tolerance, de-
pending on their maturation status: immature DCs induce tolerance and mature DCs induce
immunity.
To further study signals in DCs that control the decision between immunity and tolerance,
we focused on CD40, a signal known to induce incomplete maturation of DCs with regard to
expression of costimulatory molecules and cytokines, but to be important for DC licensing.
To investigate the influence of a CD40 signal over a longer period of time and without the
effects of the mAb on other cell types, we generated transgenic mice, where DCs receive a
tonic CD40-stimulus.
These transgenic animals showed only moderately activated DCs in the spleen in terms
of costimulatory molecules and cytokine production. At the same time animals developed
a strong colitis, characterized by abundant Th1 and Th17 cell in gut and other organs as
well as by highly elevated levels of proinflammatory cytokines like TNF-𝛼 and IL-6. Disease
development was shown to be dependent on commensal bacteria as well as B and T cells.
In these animals we also observed a strong reduction of CD103+ DC cells in the lamina
propria of the gut and additionally in the mesenteric lymph node (mLN). This was accompa-
nied by the absence of induced Tregs in colon and mLN and at the same time the presence
of more Th1 and Th17 cells.
These data show that a CD40 stimulus on DC produces incompletely matured DCs in the
spleen. But in peripheral organs the same signal induces migration into the draining lymph
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nodes and DCs functionally change in a way that prohibits the induction of tolerance. This
represents a potential mechanism by which activated CD40L+ T cells can influence immune
responses by inhibiting the induction of tolerance.
2 Zusammenfassung
Die Selbst-/Fremdunterscheidung ist eines der Hauptmerkmale des Immunsystems höherer
Tiere. Während die Erkennung von Selbstantigen Toleranz induzieren sollte, löst die adäquate
Erkennung von Fremdantigen eine Immunreaktion aus. Ein empfindliches Gleichgewicht zwis-
chen der Induktion von Immunität und Toleranz ist besonders wichtig an Körperoberflächen
wie dem Darm, wo außerdem fremdes, kommensales Antigen toleriert werden muss. DCs
spielen eine Schlüsselrolle in diesem wichtigem Gleichgewicht, da sie in der Lage sind beides,
Toleranz und Immunität, in Abhängigkeit von ihrem Reifestatus zu induzieren: unreife DCs
induzieren Toleranz und reife DCs induzieren Immunität.
Um die Signale, welche die Entscheidung zwischen Toleranz und Immunität kontrollieren,
weitergehend zu studieren, haben wir uns auf CD40 fokussiert, ein Signal von dem man weiß,
dass es eine unvollständige Reifung von DCs im Bezug auf kostimulatorische Moleküle und
Zytokine induziert, aber dennoch wichtig für die Lizensierung der DCs ist.
Um den Einfluss eines CD40 Signals über einen längeren Zeitraum und ohne die Effekte
des mAbs auf anderen Zelltypen zu untersuchen, generierten wir eine transgene Maus, in der
DCs einen tonischen CD40 Stimulus erhalten.
Diese transgenen Tiere zeigten nur leicht aktivierte DCs in der Milz was die Expression
von kostimulatorischen Molekülen und Zytokinen angeht. Gleichzeitig entwickelten sie aber
eine starke Colitis, die sich durch eine hohe Frequenz von Th1 und Th17 Zellen in Darm und
anderen Organen sowie ein erhöhtes Niveau von proinflammatorischen Zytokinen wie TNF-𝛼
und IFN-𝛾 auszeichnete. Die Entwicklung der Krankheit war abhängig von kommensalen
Bakterien sowie B- und T-Zellen.
Außerdem beobachteten wir in diesen Tieren eine Reduktion von CD103+ DCs in der Lam-
ina Propria des Darms und im mLN. Dies wurde begleitet von der Abwesenheit induzierter
Tregs in Colon und mLN bei einer gleichzeitigen Erhöhung von Th1 und Th17 Zellen.
Diese Daten zeigen, dass ein CD40 Stimulus unvollständig gereifte DCs in der Milz pro-
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duziert. In peripheren Organen aber induziert das gleiche Signal eine Wanderung in den
Lymphknoten und ändert die Funktionalität der DCs in einer Art und Weise, welche die
Induktion von Toleranz verhindert. Dieses stellt einen potentiellen Mechanismus dar, mit
dessen Hilfe aktivierte, CD40L+ T-Zellen eine Immunantwort durch Verhinderung der Toler-
anzinduktion beeinflussen können.
3 Introduction
3.1 The immune system
A hallmark of all higher animals is the ability to distinguish between self and non-self. By this
multicellular organisms protect themselves against different kinds of pathogens (e.g. viruses,
bacteria, protozoans).
The immune system of vertebrates is divided into two arms. The first is the so called innate
immunity, that consists of different layers such as mechanical barriers, like mucus and skin,
antibacterial peptides, such as 𝛼-defensins and finally cellular components, like NK cells and
granulocytes. The innate immune system is characterized by a very fast reaction rate. But at
the same time the receptor repertoire is smaller for the respective antigens and less diverse.
The second arm is the so called adaptive immunity. It consist of B and T cells. Contrary to
their innate counterparts the antigen receptors of B and T cells are of very high affinity. This
high affinity is accomplished in a process called V(D)J-recombination in which an immense
variety of different receptor specificities is generated by a limited amount of genetic segments.
These are recombined in a semi-random fashion and allow the adaptive immune system to
generate cells that recognize virtually all possible foreign- (and self-) antigens. The cost for
this high affinity on the other hand lies in very low precursor frequencies. This low abundance
leads to a slow reaction time of these cells when they first encounter their antigen, since they
have to undergo several rounds of cell devision, before they are ready to fight pathogens.
In the end the innate immune systems is therefore capable of reacting very fast, but only
to a limited number of different structures, while the adaptive immune system reacts much
slower, but is able to fight a broad range of antigens.
The second problem arising from the semi-random generation of T and B cell receptors
(TCR and BCR) is that a receptor generated in such a way has the potential to react against
self-antigens and therefore another step of quality control is necessary. This step is called
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tolerance induction and will be discussed in detail later on.
3.2 Dendritic Cells
One key component of the immune system are cells that are capable of taking up antigen and
present it in a form that can be recognized by other cells of the immune system. Cells that
fulfill this task are so called antigen presenting cells (APCs) and they include macrophages
and dendritic cells (DCs). DCs have first been described by Ralph Steinman in 1973 [1], as
cells with a tree-like form (gr. dendron = tree). In a series of following papers he showed
that this cell type is very potent in inducing mixed lymphocyte reactions [2]. Although the
role and special abilities have been subject to controversial debate, now, forty years and one
nobel prize later, the important role of DCs in the induction of tolerance and immunity as
well as the mere existence of DCs as a separate linage is widely accepted.
3.2.1 Development and heterogeneity of DCs in vivo
After Steinman had described DCs in the spleen it was soon discovered that Langerhans cells
(LCs), first described by Paul Langerhans in 1868, share a lot of features with DCs [3]. With
this finding the idea that DCs may exist in other organs than the spleen and that this type
of cell might show a certain degree of heterogeneity in vivo was born.
Today two main branches of DCs are distinguished. On the one hand the DC type discov-
ered by Steinman, that has been termed classical DC (cDC) and on the other hand the so
called plasmacytoid dendritic cells (pDC). The latter subset is characterized by a plasma cell
like shape and the ability to secrete large amounts of type-I interferons in response to viral
encounter (reviewed in [4]).
The focus of this work lies on cDCs and the diversity of the different DC subsets in lymphoid
and non-lymphoid organs as well as their roles in the induction of tolerance and immunity.
All this will be discussed in the following sections.
Very important for the establishment of DCs as an independent lineage was the identi-
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fication of distinct precursor cell types with the potential to differentiate into independent
DC subsets. This precursor has lost the potential to differentiate into other cell-types of the
myeloid or lymphoid lineages.
As all hematopoietic cells, DCs develop from the hematopoietic stem cell (HSC) via several
distinct precursor stages into the final DC. One of the first of these precursors is the so called
common myeloid progenitor (CMP) that still has the potential to give rise to monocytes,
macrophages, granulocytes, erythrocytes and megakaryocytes as well as DCs. This CMP
then differentiates via the granulocyte-macrophage precursor (GMP) into the macropage/DC
progenitor (MDP) that is able to give rise to many macrophage and DC subsets [5].
As shown in Fig.3.1 the developmental tree branches of into a common DC precursor (CDP)
as well as monocytes.
CDPs can still give rise to pDCs and the precursor of cDC (preDC) [7]. These preDCs can
be found in the blood circulation and do seed lymphoid as well as non-lymphoid tissue were
they finally differentiate into DCs [7].
3.2.2 CD8+ Dendritic cells
cDC can be further divided into CD11b+ DC or CD8+/CD103+ expressing DCs [8, 9]. These
subsets can be found in lymphoid as well as in non-lymphoid tissue. The CD8+ DCs were the
first subset of DCs that has been described in the murine system [10]. In non-lymphoid tissue
the equivalent subset is not characterized by the expression of CD8 but instead by CD103
expression [11, 12]. It recently became clear that Xcr1, a cytokine receptor, is expressed in
lymphoid as well as non-lymphoid CD8/CD103+ DC and thereby is a unifying marker for
this DC subset [13, 14].
Cells of this subset share a common transcription profile that sets them apart from other
leukocytes [15]. This specific pattern also leads to a unique protein signature for example
in the expression of lectins by the CD8+ subset. These include among others Clec9a and
DEC205 [16, 17]. The latter is one of the most studied receptors and has been shown to
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Figure 3.1: Development of different DC subsets and macrophages from the HSC to the mature
cell type. Figure is adapted from [6].
mediate antigen uptake and subsequent cross-presentation of antigens [16].
CD8/CD103+ DCs are very effective in presenting exogenous antigen on major histocom-
patibility complex class I molecules (MHCI), a process termed cross-presentation. This has
been described for splenic DCs [18] as well as DCs from non-lymphoid organs [19]. CD8+
DCs also produce high amounts of IL12p70 upon stimulation with TLR-ligands [20].
The development of CD8/CD103+ DCs is dependent on a group of different transcription
factors. These include the inhibitor of DNA binding 2 (Id2), the basic leucin zipper transcrip-
tion factor ATF-like 3 (Batf3) and the IFN regulatory factor 8 (IRF8) as well as the nuclear
factor interleukin 3 regulated (NFIL3). The absence of either of these results in a severe
impairment in the CD8/CD103+ fraction of the DCs, while at the same time the CD11b+
compartment was unaffected [21, 22, 23, 24, 25]. Interestingly, the absence of BATF3 on the
129S6/SvEv-background leads to the complete absence of CD8+ and CD103+DC in spleen
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and periphery, while on the C57BL/6 background CD103+ DC are completely absent, while
CD8+ DCs are only reduced in the spleen and normal in lymph nodes (LN) [23, 26].
3.2.3 CD11b+ Dendritic cells
The CD11b expressing DC subset is the predominant one in all lymphoid organs except for
the thymus [27]. This subset in most cases does not express CD8 or CD103. In the spleen the
CD11b+ subset can be further divided into ESAMℎ𝑖 cells that are of pre-DC origin and require
signaling via the neurogenic locus notch homolog protein 2 (Notch2) for their development
and ESAM𝑙𝑜𝑤 cells that are probably derived from an early precursor form like the MDP
[28]. These different subsets also express other markers such as CD4 to varying degrees and
additionally do not have a unifying gene expression signature. In contrast to CD8+ DC,
CD11b+ DC are inefficient at cross-presenting antigen but produce more IL-6 and IL-23 and
are better equipped to induce CD4 T cell responses [16, 29, 30].
The development of CD11b+ DC is dependent on the transcription factors v-rel avian
reticuloendotheliosis viral oncogene homolog B (RelB), Notch2, recombining binding protein
suppressor of hairless (RBP-J), IRF2 and IRF4 [28, 31, 32, 33, 34].
3.2.4 The mononuclear phagocytes of the intestine
In recent years the focus of immunological research shifted more towards non-lymphoid tissues
of the body and so scientists in the field started to characterize DC subsets found in other
tissues, such as the lamina propria of the small and large intestine.
A problem that one faces when looking at mononuclear phagocytic cells in the gut is that
tissue macrophages do also express CD11c and in many instances are also positive for MHCII
[35, 36]. Hence it is not sufficient to analyze for CD11c- and MHCII-expression to differentiate
bona fide DC from macrophages. It has been shown that this problem can be solved by the
use of additional markers, such as CD103 as a marker for DCs and CX3CR1 and CD64 or
F4/80 as markers for macrophages [37, 38, 39]
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Although CX3CR1+ cells have initially been considered DCs, it has been shown recently
that they show classical features of macrophages. In addition to the above mentioned mark-
ers they show a high phagocytic activity, cytoplasmic vacuoles, abundant cytoplasm and
cannot migrate [37, 40]. The strong phagocytic activity is combined with the ability to form
protrusions across the epithelial layer of the gut and to sample the gut lumen for antigen [41].
In contrast to DCs in lymphoid organs, which are either positive for CD103/CD8 or CD11b,
DCs of the lamina propria can be divided into three subsets on the basis of CD103 and CD11b
expression. In the small intestine the majority of DCs express CD11b, while the situation is
reversed in the colon [42]. These cells do not only resemble DCs in that they express certain
surface markers, but they also have functional properties that are archetypal for DCs. They
have been shown to migrate between the lamina propria and the draining mLN at steady
state, as well as after administration of toll-like receptor (TLR) ligands [39, 43]. Additionally
they are able to prime naïve T cells, induce these T cells to home towards the gut [44] and
are derived from classical DC precursor populations [45].
More recently a new population has received much attention. This subset is characterized by
an intermediate expression of CX3CR1 and comprises a mixture of monocytes, macrophages
and DCs. The majority are recently extravasated Ly6Cℎ𝑖monocytes that stepwise differen-
tiate into macrophages and thereby lose the expression of Ly6C and gain high expression of
CX3CR1 and CD64 [37, 38]. But this CX3CR1𝑖𝑛𝑡 population also contains bona fide DCs.
These DCs express no F4/80 but Zbtb46, a DC-specific transcription factor [46], can migrate
in a CCR7-dependent manner and proliferate in response to FLT3L [43, 47].
One of the most prominent features of the CD103+DCs is their ability to induce naïve T
cells to become regulatory T cells (Tregs) [48, 49]. This is due to their ability to generate high
amounts of retinoic acid (RA) via aldehyde dehydrogenases as well as the ability to convert
latent into active TGF-𝛽 using 𝛼v𝛽8 integrin [48, 49, 50]. However, which CD103+ subset
plays a role in the induction of Tregs remains to be resolved, since the ablation of either one
of those does not lead to a decrease in Treg cell numbers in the lamina propria [23, 29]. A
reduction in Tregs in the lamina propria was only observed in a mouse model where both
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CD103+ subsets were depleted [51], which would argue for a certain degree of redundancy
between the two subsets.
Furthermore CD103+DCs of the gut associated tissue (GALT) are also able to react ap-
propriately towards environmental cues and induce immune reactions if necessary. It has
been shown that they lose their tolerogenic properties during intestinal inflammation in-
duced by dextran sodium sulfate (DSS) [52]. In a model of aspergillus fumigatus infection
CD103+CD11b+ DCs were shown to be important for Th17 response induction [30] and in
another study even a role in steady-state Th17 induction was found [29].
3.3 DC maturation and its role in induction of immunity
or tolerance
As already mentioned in the beginning, the semi-random process, in which T and B cell-
receptors are generated, makes it necessary that the newly formed receptors are tested for
self-reactivity. This is done in a process called tolerance induction. For T cells this happens
in the thymus and for B cells in the bone marrow. Cells that pass these tolerance induction
then can go on to the periphery and, if primed, can very efficiently fight pathogens.
DCs are uniquely well equipped for both tolerance as well as induction of an immune
responses for several reasons. First, they are located in the periphery or in parts of the spleen
that are in constant contact with antigens from the circulation, namely the marginal zone.
Both locations allow for constant sampling of their surroundings for antigen.
Second, they are very efficiently taking up antigen for processing and presentation (reviewed
in [53]).
The third point worth mentioning in this context is the ability of DCs to migrate into the
T cell zones, in both, inflammatory and steady state conditions [54].
And the last reason is of course their superior ability to prime naïve T cells, which was
already one of the features that Steinman described DCs to have [2].
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But the most important point that makes DCs so unique in their ability to induce both
tolerance and immunity is their high degree of plasticity. They are either functionally and
phenotypically "immature" or, after encounter of pathogens, "mature". DCs sense the pres-
ence of so called "pathogen associated molecular patterns" (PAMPs) via different sets of
pattern recognition receptors (PRRs) and can then respond very precisely according to the
thread. PRRs encompass TLRs, but also receptors like nucleotide oliogomerization domain
(NOD) 1 and 2 and proteins of the retinoic acid-inducible gene 1 (Rig1) - like family. In
response to the activation via these receptors DCs upregulate MHC (signal 1), costimulatory
molecules, such as CD80 and CD86 (signal 2) and start the production of cytokines such
as IL-12 (signal 3). Additionally, they shut down antigen uptake and start to migrate into
lymphatic organs. T cells that encounter specific antigen on immature DCs receive signal 1
(MHC/peptide-TCR interaction) but not signals 2 and 3, since DCs do neither upregulate
costimulatory molecules nor cytokines needed for cell fate decision of T cells.
In recent years immature DCs were defined as MHCII𝑙𝑜𝑤costim𝑙𝑜𝑤, although the term was
originally intended to include a functional component. This newer definition is somehow
problematic since there are instances described in the literature where phenotypically mature
DCs were able to induce tolerance [55].
3.3.1 Central tolerance
Central tolerance is induced in primary lymphoid organs, where the respective lineage devel-
ops. B cells are tested in the bone marrow, while T cells are selected in the thymus.
T cells that react strongly with MHC-peptide complexes in the thymus can either be con-
verted into Tregs or undergo apoptosis. It has been shown that DCs play vital roles in both
of these processes [56, 57]. In a model of constitutive DC depletion it could also be shown
that the absence of DCs impairs negative selection in the thymus and leads to a higher output
of autoreactive T cells from the thymus of these animals and finally to the development of
autoimmunity [58]. The latter study on the other hand is controversial, since a different group
3.3 DC maturation and its role in induction of immunity or tolerance 13
independently generated the same mouse model and could not reproduce the findings of au-
toimmunity but instead claimed that the observed pathologies are not due to autoimmunity
but due to a myleoproliferative disease as a result of abundant FLT3L [59]. The differences
between this two studies have not yet been completely worked out.
3.3.2 Peripheral tolerance
While negative selection in the thymus deletes most of the autoreactive T cells, it is still
an incomplete process. To keep up tolerance towards antigens that have not been selected
against in the thymus, peripheral mechanisms have to be in place, to fill this gap. For the
reasons mentioned above, DCs are especially well equipped for this task and there are several
studies that show a role of DCs in the induction of peripheral tolerance [60]. T cells that
encounter their antigen on immature DCs are then either driven into anergy, a state of T
cell-unresponsiveness, or can be turned into Tregs. These, peripherally induced Tregs, will be
called iTregs in this thesis.
iTregs
The importance of iTregs was underscored in experiments using in vitro generated Tregs. It
is well documented that mice without the ability to form Tregs die shortly after birth [61].
And while thymus-derived "natural" Tregs (nTregs) are indispensable to prevent lethality of
FoxP3-deficient mice, iTregs are important to avoid the development of autoimmunity and
chronic inflammation for example in the gut [62]. This nicely shows, that nTregs are more
important to prevent the fatal outcome, but iTregs are needed to preclude certain, special
aspects of chronic inflammation. This is in line with findings showing a role of certain bacterial
strains in the induction of iTregs [63] and big differences between TCR repertoires of nTregs
and iTregs [64], reflecting the different antigens recognized.
The development of FoxP3+ iTregs has been shown to critically depend on a stretch of
conserved DNA in the FoxP3-promotor region, called "conserved non-coding DNA sequence-
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1" (CNS1) [65]. Animals with a deletion of this region showed a strong reduction of iTreg
generation in GALT and other parts of the periphery. Although these animals lack most of
the iTregs, they did not develop any autoimmunity and were also not more susceptible to
DSS-induced colitis. While this is surprising, it might be explained by an increase in the
development of other regulatory cells in the periphery, like Tr1 cells, that might compensate
for the loss of FoxP3+ Treg-induction [65].
The phenotypic differentiation of nTregs and iTregs in vivo has been a topic of great
controversy in the literature. Early on Helios, a member of the Ikaros-transcription factor
family, has been proposed as a marker exclusively expressed on nTregs [66]. This expression
of Helios might also be influenced by the way that the cells are activated, when the Treg-cell
program is induced and by the type of APCs involved [67, 68].
Another marker that has been shown to be expressed preferentially on nTregs, is the
molecule Neuropilin-1 (Nrp1) [69, 70]. This is a very attractive marker for nTreg vs iTreg
discrimination, since it is an extracellular molecule, which would allow easy purification of
iTregs. However it has also been shown, that under inflammatory conditions iTregs can
upregulate Nrp1 [70].
Very recently the lab of Gerad Eberl developed a new way to distinguish between iTregs
and nTregs. They showed that a subset of FoxP3+ cells does also express the transcription
factor ROR𝛾t and is negative for Helios [71]. These cells can be found in small numbers
throughout the body, but are strongly increased in mLN and the lamina propria of small and
large intestine. They can not be found in young animals before weaning, but increase over
time, and their development is also blocked in germ-free animals. Interestingly they are also
not found in animals that lack DCs, which again highlights the importance of DCs in the
induction of peripheral tolerance.
DCs in peripheral tolerance induction
To test the influence of DCs on the induction and the upkeep of Treg cells several DC depletion
models have been employed. A complete and constitutive deletion of DCs did not change the
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thymic Treg output and also in the periphery no differences were detected [58, 59]. Contrary
to this, another study found a correlation between the numbers of DCs and Tregs per animals
[72]. In opposition to the first two studies the latter used no chronic depletion, but on the one
hand an induced reduction and on the other hand an induced increase in DC numbers. In
these induced models they were able to observe a positive correlation between DC and Treg
numbers. A chronic depletion might lead to compensatory mechanisms, rescuing a reduced
Treg induction, while the use of CD11c-Cre on the other side might have side effects in other
cell populations.
A series of studies addressed the role of DCs in tolerance induction by targeting antigen to
certain DC subsets using different mAbs [16, 73, 74]. Adoptively transfered T cells were very
well tolerized in this animals, when mAb conjugates were injected at steady state, without
further adjuvants. One question addressed by this targeting strategy was whether different
subsets of DCs show varying potential to induce tolerance and if there may even exist a subset
that exclusively induces tolerance. Initial experiments to solve this question were carried out
by the Nussenzweig lab, where the above described targeting approach was used to target
antigen to CD8+ and CD11b+DCs and both subsets could induce tolerance [16].
In order to avoid problems arising from potential signaling functions of the targeted recep-
tor, genetic models have been generated. The antigen is here expressed using a loxP-flanked
stop-cassette in front of the antigens, which is excised using a tamoxifen-inducible CD11c-
Cre molecule [75]. This study also confirmed the potential of DCs to induce peripheral T cell
tolerance in vivo, although it does not allow to differentiate DC subsets, since all DCs and
most macrophages are positive for CD11c.
The first study claiming a special role for a certain subset was published in 2007 by the
group of Fiona Powrie, who showed that CD103+DCs from the small intestinal lamina propria
and the mLN were superior in inducing Tregs when compared to CD103−DCc [48]. This study
showed that Treg induction is dependent on the ability of CD103+DCs to metabolize vitamin
A to produce RA and on the presence of TGF-𝛽. Other studies following the initial one
showed, that one of the key features of CD103+DCs, that enables them to induce Tregs, is
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the expression of the integrin 𝛼v, that can convert latent into active TGF-𝛽 [76].
DCs of the lamina propria comprise two different CD103+ subsets, one of them coexpressing
CD11b, while the other one does not. The initial studies however did not address if these are
different in their potential to induce Tregs. The CD103+CD11b− subset is developmentally
dependent on the transcription factor Batf3 and can therefore be depleted by the knock-out of
Batf3 [23]. Using this knock out mice, no differences in the Treg-compartment of the lamina
propria were observed. Additionally, the animals did not show any signs of intestinal inflam-
mation or higher susceptibility to dextran sodium sulfate (DSS)-induced colitis in contrast to
animals having all DC subsets.
The CD103+CD11b+ subset on the other hand has been shown to express the human
langerin molecule in a transgenic setting and can therefore be depleted using a human langerin-
DTA mouse model [51]. When these animals were crossed to a Batf3−/− background, thereby
deleting both CD103+DC subsets in the lamina propria, a moderate reduction in the Treg
number of the lamina propria was observed. This was accompanied by a reduction in the
frequency of CCR9+Tregs, a marker which cells have to upregulate to enter the lamina propria.
Taken together, it seems as if both CD103+ DC subsets in the GALT can induce iTreg
development. This would fit to a model, in which the environment, a DC is derived from, is
more important for its tolerogenic potential, than the mere subset it belongs to.
The idea that the environment is very important for the potential of DCs to induce tolerance
is further strengthened by the observation, that CD103+ DCs also lose their ability to induce
iTregs during colitis [52]. This of course goes back to the idea, that immature DCs excel at
inducing tolerance, while mature DCs would induce an immune response.
In line with the idea of the environment being important for tolerance induction is the
fact, that oral administration of antigen is superior to any other way that an antigen could
be administered, when it comes to tolerance induction [77, 78]. This phenomenon is called
oral tolerance. It can also be seen, when transgenic T cells are transfered into animals that
receive their respective antigen orally. The T cells respond to this by converting to FoxP3
expressing Tregs [49]. For this process the antigen has to be taken up, processed and then
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presented to the naïve T cells within the mLN or other lymphoid structures. Here DCs are
essential, because even though macrophages are able to sample luminal content of the gut
and take up such antigen [41], they are unable to migrate [39] and therefore do not reach
lymphoid structures to interact with T cells and induce FoxP3 expression. The transport of
this antigen is actually achieved by DCs, that either can take up the antigen themselves [79]
or can take over antigen from macrophages via gap-junction proteins [80].
This, together with the above mentioned ability to generate molecules like RA and TGF-𝛽,
makes DCs absolutely essential in the induction of oral tolerance.
3.4 The influence of CD40 on DCs
CD40 is a transmembrane glycoprotein with a molecular mass of 48 kDA. Its role has initially
been investigated predominantly in B cells, where CD40 has a proliferative effect when bound
by its ligand CD154 (CD40L). However, CD40 is not just expressed by B cells, but instead
also on monocytes, epithelial and endothelial cells as well as on DCs.
The role of CD40 signaling in DCs is less well understood then its role in B cells. It
has been shown by different groups that the ligation of CD40 on DCs matures them and
therefore makes them more effective at antigen presentation via upregulation of MHCII and
costimulatory molecules [81, 82, 83]. This means that signal 1 and 2 can be delivered by DCs
that have been been activated via CD40.
It is less clear whether DCs, activated this way, are able to deliver a signal 3 to T cells. It
has been shown that CD40 ligation on DCs leads to production of proinflammatory cytokines
like IL-12 [84] in vitro and that the injection of anti-CD40 mAb has immunostimulatory
effects in vivo, when antigen is delivered directly to certain DC subsets [73, 74]. In contrast,
several studies show that CD40 ligation on DC alone is not sufficient, but it always needs a
combination of CD40-signal and TLR-ligand to get a full activation of DCs [85, 86, 87].
The discrepancy between these studies may have several reasons. The first reason is that
when anti-CD40 mAb is used in vivo, it does not only have an effect on DCs but also on
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other cells expressing CD40, most notably B cells. And it has been shown that this leads,
among other effects, to liver inflammatory disease, that is supposed to be dependent on B
cells being present [88]. Therefore it is unclear whether the observed DC maturation is only
due to anti-CD40 treatment or if a mixture of this and proinflammatory cytokines / danger
signals released from necrotic liver cells is responsible for the maturation of the DCs. The
second reason concerns studies that have been carried out in vitro. Here the cells are under
the influence of growth-factors as well as serum and plastic, so that again the results of
mixed influences on DCs are observed. Because of the above mentioned reasons in vivo data
gathered using mAb-injection is of limited use.
Another very interesting effect of anti-CD40 in vivo is limited to the CD103+ subset of
DCs. The group of Fiona Powrie could show that the injection of anti-CD40 mAbs leads
to the disappearance of CD103+MHCII+ cells from the spleen after injection into Rag−/−
animals. Additionally the expression of CD103 on sorted CD103+ DCs was lost after they
were incubated with anti-CD40 in vitro [89]. Rag−/− animals injected with anti-CD40 mAb
suffered from wasting disease that could not be prevented by the transfer of regulatory T cells.
Because of the role of CD103+ DCs on the peripheral induction of tolerance, the depletion of
these cells by the application of a mAb is a possible valuable tool to investigate their role in
vivo. At the same time it is limited due to the described side effects of the mAb application.
To study the influence of CD40 without these interfering influences, we developed a mouse
model in which selectively DCs receive a constitutive CD40 signal.
3.4.1 The DC-LMP1/CD40 mouse model
To generate a model in which only DCs receive a CD40 signal, we made use of the LMP1/CD40
model developed in the laboratory of Ursula Zimber-Strobl [90]. In this mouse a Stop-cassette
flanked by two loxP sites and followed by the gene for the fusion protein LMP1/CD40 was
knocked into the rosa26 locus of the mouse (fig. 3.2). Since the rosa26 locus is transcriptionally
very active one can be certain that the fusion protein is expressed optimally.
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In this study the LMP1/CD40 mouse was crossed with a mouse strain expressing the Cre
recombinase under the control of the CD11c promotor. CD11c is almost exclusively expressed
by DCs and macrophages [31]. Because of that we termed this mouse strain DC-LMP1/CD40.
The fusion protein LMP1/CD40 consists of the transmembrane domain of the Ebstein-Barr
virus (EBV) protein LMP1 (amino acids 1-187) coupled to the intracellular part of the human
CD40 domain (aa 223-280). EBV infects B cells and can establish a live long persistence in
these cells and can also potentially cause malignant lymphoproliferative disorders in individu-
als that are immune compromised. To achieve this, EBV expresses six nuclear proteins (EBV
nuclear antigens, EBNA) and two latent membrane proteins (LMP1 and LMP2a). LMP1 has
many similarities to CD40 when it comes to its function in B cell proliferation and survival.
The protein consists of a short N-terminal cytoplasmic tail, six transmembrane domains and
a long C-terminal cytoplasmic tail and is the necessary factor in the immortalization of B cells
in vitro. The transmembrane part allows LMP1 to aggregate and thereby facilitates ligand
free signaling via recruitment of TRAFs [91]. LMP1 and CD40 signal transduction leads to
the activation of NF-𝜅B, JNK as well as p38/MAPK [92, 93].
The second part of the fusion protein is the intracellular part of the human CD40 molecule.
It has previously been shown that a human CD40 molecule can rescue the phenotype caused
LMP1/CD40STOP
loxP)sites
LMP1/CD40
+)Cre)recombinase)(expressed)under)CD11c)promoter)
rosa26)locus
LMP1/CD40flSTOP
DC-LMP1/CD40
XbaI
Figure 3.2: Schematic representation of the rosa26 locus in LMP1/CD40 mouse (middle panel)
as well as in DC-LMP1/CD40 mice (bottom panel).
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by the deletion of the mouse CD40 molecule [94].
Chimeric molecules of LMP1 and CD40 have been shown to be able to deliver ligand-free
signals very similar to normal CD40 signals in vitro [95].
The first in vivo use of the chimeric molecule was reported in a model were the LMP1/CD40
molecule was activated using a CD19-Cre [90]. As expected, the chronic CD40 stimulus lead
to B cell lymphoma development in mice older then 12 weeks, further underscroring the role
of CD40 signaling in B cell proliferation and survival.
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3.5 Aim of the thesis
DCs are uniquely well equipped to induce both tolerance and immunity. The decision which
of the two is induced is thought be made dependent on the maturation status of a DC. This
in turn can be influenced by a broad variety of different stimuli. One of them is CD40 which
is discussed in the literature as both, immune stimulatory, but also showing potential to
generate tolerogenic DCs.
The goal of this study was to circumvent disturbing factors of anti-CD40 mAb treatment
and instead to investigate the effects of a CD40 signal delivered to DCs directly and how
this influences their potential to induce tolerance or immunity. To this end we generated
a transgenic mouse model in which DCs receive a constant, ligand-free CD40 signal under
the control of the CD11c promotor. This allowed us to investigate in vivo the influence of a
CD40 signal on the tolerogenic potential of DCs in general, but also gave us the opportunity
to analyze the potential at different sites of the body.
4 Material and Methods
4.1 Materials
4.1.1 Devices
Analytic scale (Adventurer, Ohaus Corp., Pine Brooks, NJ, USA), automatic pipettors (Inte-
gra Biosciences, Baar, Switzerland), bench centrifuge (Centrifuge 5415 D, Eppendorf, Ham-
burg, Germany), cell counter (CASY cell counter and analyzer, OMNI life science, Bremen,
Germany), centrifuge (Rotixa RP, Hettich, Tuttlingen, Germany), chemical scale (Kern, Alb-
stadt, Germany), ELISA-reader (𝜈max kinetic microplate reader, Molecular Devices, Biber-
ach, Germany) tissue homogenizer (FastPrep-24, MP Biomedicals, Santa Ana, CA, USA),
flow cytometer (FACSCalibur, FACSCantoII and FACSAria, BD), incubator (Hera cell, Her-
aeus Kendro Laboratory Products, Hanau, Germany), laminar airflow cabinet (Heraeus),
magnetic stirrer (Ika Labortechnik, Staufen, Germany), PCR-machine (Biometra, Goettin-
gen, Germany), pH-meter (Inolab, Weilheim, Germany), pipettes (Gilson, Middleton, WI,
USA), power supply (Amersham Pharmacia, Piscataway, NJ, USA), real-time PCR machine
(CFX96 Real Time System, BIO-RAD, Hercules, CA, USA), vacuum pump (KNF Neuberger,
Munzingen, Germany), vortex-Genie2 (Scientific Industries, Bohemia, NY, USA), water bath
(Grant Instruments Ltd., Barrington Cambridge, UK).
.
4.1.2 Consumables
disposable syringe filter (0.2 + 0.45 𝜇m) Nalgene Nunc Int., Rochester, NJ, USA
disposable injection needle (26 G x 1/2”) Terumo Medical Corporation, Tokyo, Japan
disposable syringe (1+5 ml) reaction Braun, Melsungen, Germany
reaction container 5 ml (FACS) BD, Franklin Lakes, NJ, USA
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reaction container 15 ml and 50 ml Greiner, Frickenhausen, Germany
BD Microtainer BD, Franklin Lakes, NJ, USA
4.1.3 Chemicals
Unless stated otherwise, chemicals were purchased from Merck (Darmstadt, Germany), Roth
(Karlsruhe, Germany) or Sigma-Aldrich (St. Louis, MO, USA). All buffers and solutions were
prepared using double distilled water.
4.1.4 Buffer and media
ACK: 8.29 g NH4Cl
1 g KHCO3
37.2 mg Na2EDTA
H2O ad 1 l
pH 7.4
PBS: 137 mM NaCl
2.7 mM KCl
10 mM Na2HPO4
2 mM KH2PO4
pH 7.4
HBSS: 137 mM NaCl
5.4 mM KCl
0.25 mM Na2HPO4
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0.1 g glucose
0.44 mM KH2PO4
1.3 mM CaCl2
1.0 mM MgSO4
4.2 mM NaHCO3
HBSS-EDTA: HBSS
8 % (v/v) FCS
10 mM EDTA
10 mM HEPES
FACS buffer: PBS
2 % (v/v) FCS
0.01 % (v/v) NaN3
T cell-medium: RPMI
10 % (v/v) FCS
100 U/ml Penicillin
100 g/ml Streptomycin
500 mM 𝛽-mercaptoethanol
CFSE-staining buffer: PBS
0.03 % FCS
50x TAE buffer: 242 g Tris HCl
57.1 mL 100 % (v/v) acetic acid
100 mL 0.5 M EDTA (pH 8.0)
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H2O ad 1 L
10x Gitocher: 670 mM Tris HCl pH 8.8
166 mM (NH4)2SO4
65 mM MgCl2
0.1% (v/v) gelatin
1x Gitocher buffer: 5 𝜇L 10x Gitocher buffer
2.5 𝜇L 10 % (v/v) Triton X-100
0.5 𝜇L 𝛽-mercaptoethanol
3 𝜇L proteinase K (10 mg/ml)
39 𝜇L H2O
4.1.5 Antibodies
Table 4.3: Antibodies used in flow cytometry
epitope clone conjugate manufacturer
B220 RA3-6B2 PerCP BD Bioscience
CD3 145-2C11 PE-Cy7 ebioscience
CD4 GK1.5 PE, PE-Cy7, APC BD Bioscience
CD8 53-6.7 BV 421, APC-eFlour780 ebioscience
CD11b M1/70 APC-eFlour780 BD Bioscience
CD11c N418 PE-Cy7, APC BD Bioscience
CD25 PC61.5 PerCP-Cy5.5 ebioscience
Continued on next page
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Table 4.3 – continued from previous page
epitope clone conjugate manufacturer
CD44 IM7 FITC BD Bioscience
CD45 30.F11 PerCP, BV 421 biolegend
CD45.1 A20 eFlour450 biolegend
CD45.2 104 APC biolegend
CD45RA 14.8 PE BD Bioscience
CD62L MEL-14 APC BD Bioscience
CD64 X54-517.1 APC biolegend
CD70 FR70 biotin ebioscience
CD80 16-10A1 biotin ebioscience
CD86 GL-1 biotin BD Bioscience
CD90.1 OX-7 PerCP BD Bioscience
CD103 M290 PE BD Bioscience
CD172a P84 APC BD Bioscience
FoxP3 FJK-16s AlexaFlour647 or eFlour660 ebioscience
MHCII M5/114.15.2 FITC, PerCP ebioscience
Ly6C AL-21 FITC BD Bioscience
Helios 22F6 FITC ebioscience
ROR𝛾t AFKJS-9 PE ebioscience
NK1.1 PK136 PE, PE-Cy7 BD Bioscience
TCR-b H57-597 FITC ebioscience
V-a2 B20.1 PE biolegend
F4/80 BM8 PE-Cy7 biolegend
IL-17A TC11-18H10 PE BD Bioscience
IFN-𝛾 XMG1.2 APC ebioscience
Continued on next page
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Table 4.3 – continued from previous page
epitope clone conjugate manufacturer
Streptavidin BV421 biolegend
4.1.6 Oligonucleotides, peptides and proteins
All oligonucleotides were purchased from MWG-Biotech AG (Ebersbach, Germany).
OTI- (Ova257−264, SIINFEKL) and OTII-peptide (Ova323−339, ISQAVHAAHAEINEAGR)
were purchase from PolyPeptide Group (Strasbourg, France).
Ovalbumin protein grade II and VII were bought from Sigma-Aldrich (St. Louis, MO,
USA).
4.1.7 Mouse strains
All mouse strains were bred and kept in the Institute for Immunology at the LMU Munich.
The following mouse strains have been used in this work.
Table 4.4: Genotyping primers
knock-out/transgene primer name primer sequence
Cre RO334 GGACATGTTCAGGGATCGCCA-
GGCG
RO335 GCATAACCAGTGAAACAGCAT-
TGCTG
LMP1/CD40 HL15 AAGACCGCGAAGAGTTTGTCC
HL54 TAAGCCTGCCCAGAAGACTCC
HL152 AAGGGAGCTGCAGTGGAGTA
CD40fl CD40flox_wt_fw TCTTTGGGAGCACTGAAGAG
CD40flox_wt_rv_1 TACCAAAGCAAGAACGCAGA
CD40flox_flox_rev GATCGTTGAAGAAGGAGGTG
CX3CR1 CX3CR1_wt GTCTTCACGTTCGGTCTGGT
CX3CR1_com CCCAGACACTCGTTGTCCTT
CX3CR1_mut CTCCCCCTGAACCTGAAAC
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CD11c-Cre
The CD11c-Cre mouse was produced in the Lab of Boris Reizis and expresses the Cre
recombinase under control of the CD11c promotor [31]. This mouse allows the deletion of
floxed allels in DCs and other CD11c-expressing cells.
DC-LMP1/CD40
To obtain DC-LMP1/CD40 animals, CD11c-Cre mice were crossed to LMP1/CD40 mice
[90]. The latter mouse strain carries the knock-in of the LMP1/CD40 gene which is preceded
by a floxed stop-codon into the ROSA26 locus. The cre-mediated excision of the stop codon
then leads to the constitutive expression of the fusion-protein between LMP1, derived from
EBV, and the intracellular signaling domain of human CD40. The LMP1 domain anchors
the protein in the plasma membrane and at the same time leads to a multimerization, which
in turn leads to signaling by the CD40 molecule.
DC-LMP1/CD40 x Rag1−/−
DC-LMP1/CD40 mice have been crossed onto a Rag1−/− background. Rag1−/− mice are
unable to form B and T cells due to a defect in the V(D)J-recombination machinery [96].
OTI
This mouse strain carries a transgenic T cell receptor specific for the ovalbumin-derived
peptide SIINFEKL that is presented to CD8+ T cells in the context of H-2K𝑏 [97]. The T
cell receptor of these mice uses the V𝛼2 and the V𝛽5 segments and T cells can be visiualized
using mAbs directed against these two segments.
OTII
OTII is a TCR-transgenic mouse line that carries a TCR specific for the peptide residues
323-339 of ovalbumin that are presented in the context of I-A𝑏 [98]. At the same time these
cell show crossreactivity to retroviral superantigens expressed in the thymus, which leads to
a strong negative selection.
DC-CD40 KO
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DC-CD40 KO mice were generate by crossing CD11c-Cre mice with CD40𝑓𝑙/𝑓𝑙 mice, thereby
generating a DC-specific knock-out of the CD40 molecule. These mice were generate by Prof.
Esther Lutgens and Dr. Norbert Gerdes.
4.2 Methods
4.2.1 Immunological and cell biology methods
4.2.1.1 Harvesting of blood and organs and single cell preparation
Animals were sacrificed by cervical dislocation after they had been sedated using Isoflu-
rane. Organs were removed using scissors and fine tweezers and put into RPMI medium.
Spleen, thymus and lymph nodes were then digested with DNAse I (0.2 mg/ml) and Liberase
(0.65 Wünsch units/ml, both Roche) for 30 min at 37∘C. Afterwards the organs were passed
through a 100 𝜇m cell strainer, washed once with cold PBS and red blood cells were lyzed
using ACK buffer for 5 min at room temperature. Cells were washed once again and counted
using CASY-counter (OMNI life science) and used for further analysis or experiments.
To analyze cells from the lamina propria, colon was taken from a mouse, fecal content
removed, the colon opened longitudinally and cut into ca. 5 mm big pieces. The pieces were
then incubated with HBSS-EDTA for 10 min on a shaker at 37∘C, the supernatant containing
epithelial cells was discarded and gut parts were washed twice with icecold PBS. Afterwards
the colon was digested once for 30 min and then twice for 20 min with a mixture of Collage-
nase IV (157 Wuensch units/ml, Worthington), DNAse I (0.2 mg/ml dissolved in PBS) and
Liberase (0.65 Wuensch units/ml, both Roche, dissolved in HBSS with FCS), the supernatant
was collected after each digestion and the cells were washed once with PBS.
Cells from all three digestions were combined and immune cells enriched using gradient cen-
trifugation. For this cells were resuspended in 40 % Percoll and this solution was overlayed
onto a 80 % Percoll solution. Centrifugation was carried out for 20 min at 1800 rpm and
4∘C without break. Cells at the interphase were collected, washed once and used for further
4.2 Methods 30
analysis.
4.2.1.2 Flow Cytometry staining
For flow cytometric analysis 2·106 cells were used per staining in a 96 well plate. Cells were
washed once with 100 𝜇l FACS buffer and then stained for 20 min at 4∘C in the dark in
50 𝜇l of antibody mix in FACS buffer. Each antibody has been titrated for optimal use.
After the incubation cells were washed once with 150 𝜇l FACS buffer and then either directly
acquired by FACS or fixed for overnight storage using FACS buffer containing 2 % (v/v)
paraformaldehyde.
Cell that have been stained with a biotinylated mAb were stained in a second step with
a fluorescently labeled streptavidin also in a volume of 50 𝜇l at 4∘C in dark for additional
20 min.
For intracellular stainings cell were fixed and permeabilized after they have been stained
for all extracellular markers. For the staining of FoxP3 cells were washed once and then
resuspended in 200 𝜇l 1x Fixation/Permeabilization solution (eBioscience) for at least 30 min
at 4∘C in the dark. Cells were spun down, the supernatant removed and the cells washed twice
with 1x Permeabilization Buffer (eBioscience). Cells were then stained with FoxP3-specific
antibody in 50 𝜇l Permeabilization Buffer for 30 min at 4∘C in the dark. Afterwards cells
were washed once and acquired by FACS.
Acquisition was either performed using a FACSCalibur or FACSCanto II. Cell sorting was
performed at FACSAria (all BD). Data analysis was performed using FlowJo version 8 and 9
(TreeStar, Ashland, OR, USA).
4.2.1.3 Depletion of commensal bacteria
To deplete as many commensal bacteria as possible animals were provided with a mixture of
ampicilin sodium salt (1 g/l), vancomycin hydrochloride (500 mg/l), neomycin sulfate (1 g/l)
and metronidazole (1 g/l) in the drinking water for at least 3 weeks [99].
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4.2.1.4 ELISA for commensal- and food-reactive antibodies
The cecum of C57BL/6 mice was removed, opened longitudinally, transfered into a 2 mL
eppendorf cup, containing 1.5 ml PBS and cecal content was expelled by vigorously vortexing.
Remaining cecal tissue was removed and PBS and cecal content was transfered into tubes
with Lysing Matrix E (MP Biomedicals) and then homogenized using the FastPrep system
(MP Biomedicals) for 45 s at maximum speed.
Samples were spun down and supernatant was collected, filtered and spun again at maxi-
mum speed. The protein concentration was determined and the cecal bacterial lysate (CBL)
was stored at -20∘C until used.
CBL was diluted in carbonate buffer to a final concentration of 50 ng/ml and 100 𝜇l of this
was coated per well over night at 4∘C. Wells were washed five times with PBS 0.05 % (v/v)
Tween20. Afterwards unspecific binding was blocked using 200 𝜇l PBS with 0.5 % (v/v)
MMP for two hours at room temperature and wells were then again washed five times with
PBS 0.05 % (v/v) Tween20.
Serum of mice was diluted either 1:300 or 1:600 and 100 𝜇l of this was added to a well,
incubated for two hours at room temperature and washed again for five times with PBS 0.05 %
(v/v) Tween20. For detection isotype specific antibodies coupled to horseradish peroxidase
were used at a dilution of 1:4000 in blocking buffer for 2 hours at room temperature.
After another round of washing the ELISA was developed using 100 𝜇l of 3,3’,5,5’-tetra-
methylbenzidin solution. The reaction was stopped by adding 50 𝜇l 2 N H2SO4. Optical
density was measured at a wavelength of 450 nm with 630 nm as a reference wavelength.
4.2.1.5 In vivo antigen uptake assays
To investigate uptake and processing of complete protein animals were injected with a mixture
of 100 𝜇g AlexaFlour647-Ova and 100 𝜇g DQ-Ova. Animals were sacrificed 2 hours later,
spleen taken and processed as described before for flow cytometry staining.
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4.2.1.6 Generation of bone marrow chimeras
To generate bone marrow chimera recipient mice were irradiate with two separate doses of
550 rad using a Cesium source (Gammacell 40, AECl, Mississauga, Canada). Irradiated
animals were reconstituted with 5·106 bone marrow cells, 1:1 mixed from Ly5.1+ and Ly5.2+
bone marrow. To prevent infection, animals received 1.2 g/l neomycin in water ad libitum
for 4 weeks. Animals were analyzed 8 to 10 weeks after reconstitution.
4.2.1.7 Magnetic cell sorting
To purify cell populations based on surface marker expression, magnetic cell sorting (MACS,
Miltenyi Biotec) was employed. This technique uses antibodies reactive to certain surface
antigens coupled to magnetic beads. After cells have been incubated with these antibodies for
an appropriate amount of time, cells can be applied to a column placed in a paramagnetic field.
Labeled cells are retained on the column, while unlabeled cells are washed away. Thereafter,
columns are rinsed three times and the eluted fraction can be collected. This opens the
interesting possibility of purifying cells by depleting all other cell types and not touching the
cell of interest.
This technique was actually employed when CD8+ and CD4+ T cells were purified for
adoptive transfer experiment (CD8+ T cell Isolation Kit, negative selection and CD4+ T cell
Isolation Kit, negative selection). All procedures were performed according to manufacturer
instructions.
4.2.1.8 Adoptive T cell transfer
To transfer transgenic T cells into experimental animals spleens from transgenic animals
were taken and the respective T cells purified using either CD4 or CD8 T cell enrichment
kits. Purity of the cell suspension was checked using anti-CD4 or anti-CD8 antibody in
combination with an appropriate V𝛽 antibody specific for the respective TCR.
If not stated otherwise 0.5·106 CD8+ or 2·106 CD4+ T cells were transfered intravenously
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into syngenic and sex-matched mice. Behavior of the transfered cells could be followed by
analyzing the congenic markers CD45.1 or CD90.1.
4.2.1.9 CFSE labeling and in vivo cytotoxicity assay
Cells were resuspended at a concentration of 10·106 in CFSE-staining buffer. Then CFSE
was added to a final concentration of 2.5 𝜇M, mixed immediately and incubated for 10 min
at 37∘C. Afterwards, 2 ml of FCS was added, the mixture incubated for 2 min at RT to stop
the labeling reaction and the cells were washed three times with PBS. The cells were filtered
after this and used in proliferation assays.
If the CFSE labeled cells were supposed to be used in an in vivo cytotoxicity assay, whole
spleen was divided into three equal parts, subsequently loaded with different concentrations
of peptide and then stained with different concentrations of CFSE. Cells with high peptide
concentration (2 𝜇g/ml) were labeled with 2.5 𝜇MCFSE, cells that did not receive any peptide
were labeled with 0.33 𝜇M CFSE and cells with low peptide concentration (2 ng/ml) were
labeled with 70 nM CFSE. The three groups were mixed in a 1:1:1 ratio, separation of the
peaks was verified by FACS and injected into animals that previously received cytotoxic T
cells.
After 16 h animals were sacrificed and spleens analyzed for the presence of CFSE-labeled
cells. The calculation of specific lysis was performed on the basis of two of those peaks, while
the other peak served as backup, in case of a fast killing.
Specific lysis was calculated on the basis of the ratio R, with
𝑅 =
% 𝑢𝑛𝑙𝑜𝑎𝑑𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
% 𝑝𝑒𝑝𝑡𝑖𝑑𝑒 𝑙𝑜𝑎𝑑𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
This ratio was then used to calculate the specific lysis as
𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑙𝑦𝑠𝑖𝑠 =
(︃
𝑅𝑢𝑛𝑖𝑚𝑚𝑢𝑛𝑖𝑧𝑒𝑑 𝑎𝑛𝑖𝑚𝑎𝑙𝑠
𝑅𝑖𝑚𝑚𝑢𝑛𝑖𝑧𝑒𝑑 𝑎𝑛𝑖𝑚𝑎𝑙𝑠
)︃
· 100
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4.2.1.10 In vitro T cell restimulation
To asses cytokine secretion potential of a polyclonal T cell population, animals were sacrificed
and single cell suspensions prepared as described in section 4.2.1.1. 2 · 106 cells were then put
into 96 well plates and stimulated with Phorbol-12-myristat-13-acetat (PMA) and ionomycin
in T cell-medium at a final concentration of 40 ng/ml and 1 𝜇g/ml respectively for four hours
in the presence of 2 𝜇M Golgi-Stop (BD).
Afterwards, cells were washed twice with FACS-buffer and then stained extracellularly as
described in section 4.2.1.2. To permeabilize cells, they were resuspended in 150 𝜇l of BD
Cytofix/Cytoperm (BD Bioscience) and incubated for 20 min at 4∘C in the dark, washed
once with Perm/Wash buffer (BD) and stained for cytokines of interest for 30 min at 4∘C in
the dark. Then cells were washed once again and resuspended in FACS buffer until they were
acquired.
4.2.1.11 Immunofluorescence staining
Organs were directly embedded in Tissue-Tek OCT compound (Sakura Finetek, Zoeterwoude,
The Netherlands) and snap frozen in liquid nitrogen. Sections of 5-7 𝜇m were cut using a
cryostat instrument (Leica Microsystems, Wetzlar, Germany), fixed for 20 min at -20∘C using
aceton and subsequently dried over night in the dark.
Before staining the slides were adjusted to room temperature and rehydrated for 15 min
with PBS containing 0.25 % ( w/v) bovine serum albumin (BSA). To minimized unspecific
binding, slides were incubated with PBS, 0.25 % BSA containing 10% mouse serum.
Staining was performed in a moist chamber in the dark for 30 min at room temperature.
After staining the slides were washed and cover slides put on. The slides were analyzed using
a BX41 microscope equipped with a F-view II camera and cellF software (all from Olympus,
Hamburg, Germany).
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4.2.1.12 Cytokine bead array
Blood of animals was taken via puncturing the heart. The blood was transfered into a
microtainer tube (BD, Franklin Lakes, NJ, USA) and incubated at room temperature for at
least three hours, so that the blood could coagulate. Afterwards the tube was centrifuged at
8000 rpm for 5 min at room temperature and the serum was frozen at -20∘C until use.
To measure up to six different cytokines in the same amount of serum the BD Cytokine Bead
Array mouse inflammation kit was employed. Serum samples were titered in the beginning
to ensure an optimal concentration for the assay. The assay procedure was then performed
according to manufacturers instructions.
Acquisition of the samples was performed using a FACSCantoII. Results were analyzed
using FCAP Array Software (Soft Flow Inc.)
4.2.2 Molecular biology
4.2.2.1 Agarose gel electrophoresis
To visualize DNA fragments and to separate them according to size, they were applied to gel-
electrophoresis on an agarose gel. The agarose gel was prepared by dissolving 0.8 - 2 % (w/v)
agarose in TAE buffer, depending of the fragmentsize that was supposed to be visualized. To
estimate the size of the fragments, either a 100 bp or a 1 kb ladder was used (New England
Biolabs, Ipswich, MA, USA). PCR fragments either already contained loading buffer (10 %
glycerol, xylene cyanol FF) or it was added directly before applying the sample to the gel.
DNA samples were visualized using ethidium bromide (0.5 𝜇g/mL) that was added to the gel
followed by examination with UV light (312 nm, Intas, Goettingen, Germany).
4.2.2.2 Isolation of genomic DNA and RNA
To isolate genomic DNA for genotyping, 2-5 mm of mouse tail tip was cut, put into 50 𝜇l
1x Gitocher buffer and incubated at 55∘C for 6 h. Proteinase K was inactivated at 95∘C for
5 min.
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The isolation of nucleic acids for other purposes was done using the following kit according
to manufacturers instructions:
• DNeasy Blood & Tissue Kit (Quiagen)
• RNeasy Mini Kit (Quiagen)
• RNeasy Micro Kit (Quiagen)
4.2.2.3 Transcriptional profiling of DCs
To analyze the gene expression profile of DCs under different conditions, DCs were ex-vivo
sorted using the markers indicated in the results section. Purity was assessed by FACS,
cells were washed once and then resuspended in buffer RLT (Quiagen) to disrupt the cells
and unfold all proteins. This was immediately snap-frozen and then kept at -80∘C. The
gene expression was analyzed using the mouse immunology panel for the nanostring platform
(NanoString Technologies, Seattle, WA, USA). Processing of the samples was done by a
collaboration partner.
Data analysis was performed using R and nSolver analysis software (NanoString Technolo-
gies).
4.2.2.4 Statistics
Statistical analysis was performed using PRISM software (GraphPad software, La Jolla, CA,
USA). Unless stated otherwise all bar graphs represent mean ± standard error of mean (SEM)
and significance was analyzed using a students t-test, with *: P = 0.01 to 0.05, **: P = 0.001
to 0.01 and ***: P < 0.001.
5 Results
5.1 Influence of anti-CD40 injection on DCs in different
organs
To investigate the influence of CD40 signaling on DCs, anti-CD40 mAb was injected into
Rag−/− animals, since an influence on splenic DC was already published in Rag−/− animals
[89]. Three days after injection CD103+DCs were completely absent from the spleens of
animals treated with an anti-CD40 mAb (Fig. 5.1 A). Since CD103+DCs play an important
role in peripheral tissues we also analyzed different DC subsets in the lamina propria of the
gut. Here we also observed a strong reduction of the relative amount of both CD103+CD11b−
and CD103+CD11b+ DCs while the other subset was relatively increased (Fig. 5.1 B). To test
if this effect holds true in animals that have B and T cells, anti-CD40 mAb was injected into
C57BL/6 animals and the three intestinal DC subsets were analyzed. Also in lamina propria
of T and B cell sufficient animals the two CD103+ subsets were strongly reduced, although
we found a substantial amount of remaining CD103+CD11b− cells (Fig. 5.1 B lower panel).
To look for other effects caused by the injection of anti-CD40 mAb, serum was taken and
livers were analyzed macroscopically. Again this was performed in Rag−/− animals, where we
were able to compare our results to published data and in C57BL/6 animals to see if there
are differences when B and T cells are present. We could observe the formation of white
spots in the liver of Rag−/− animals 72 h after injection, indicating an ongoing inflammation
(Fig. 5.2 A). This finding was further supported by elevated serum levels of alanin-amino-
transferase (sALT), a marker for liver damage [88]. This could be observed in Rag−/− and
C57BL/6 animals. The sALT levels were strongly increased 72 hours after injection of the
anti-CD40 mAb (Fig. 5.2 B) indicating liver damage and strong side effects.
5.1 Influence of anti-CD40 injection on DCs in different organs 38
0 103 104 1050 103 104 105
0
102
103
104
105
CD103C
D1
1c
A Rag-/-
# 
of
 C
D1
03
+  c
ell
s[*
10
6 ]
Rag-/- + anti-CD40
0.0
0.1
0.2
0.3
0.4
0.5
B CD103+CD11b- CD103
+
CD11b+
CD103-
CD11b+
%
 o
f D
C
control α-CD40
control α-CD40
C5
7B
L/
6
Ra
g-/
-
***
CD11bC
D1
03
Ctr
anti-CD40
***
%
 o
f D
C
0
10
20
30
40
50
0
5
10
15
20
25
0
20
40
60
80
100
*** ***
0
103
104
105
0 102 103 104 105
0
103
104
105
0 102 103 104 105 0
10
20
30
40
0
5
10
15
0
20
40
60
80
* **
Figure 5.1: Injection of anti-CD40 mAb leads to a reduction of CD103+ DCs in
different organs C57BL/6 and Rag−/− animals were injected with anti-CD40 mAb, sacrificed
after 72h and analyzed for the presence of CD103+ DCs. A) Live cells of Rag−/− spleens
were analyzed for the expression of CD103. Shown are representative FACS-plots of one of
three experiments (n = 3 animals per group). Statistics represents pooled results from these
three experiments. B) Expression of CD103 and CD11b on CD11c+MHCII+CD64− cells in
the lamina propria after anti-CD40 injection in C57BL/6 and Rag−/− animals. Representative
results of 3 and 2 repetitions with n= 3 respectively.
Additionally we did find a rapid increase in serum levels of proinflammatory cytokines
such as MCP-1, TNF-𝛼, IFN-𝛾 and IL-6 (Fig. 5.2 C). Serum levels of these cytokines peaked
between 16 and 24 h after injection and were back to baseline after 72 hours.
Taken together these data showed a selective reduction of CD103+ DCs after receiving
a CD40 signal. On the other hand our data also showed strong side effects caused by the
injection of the anti-CD40 mAb. This made it impossible to asses the influence that a CD40
signal has directly on DCs.
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Figure 5.2: anti-CD40 mAb induces strong liver inflammation and leads to increased
proinflammatory cytokines in serum. A) Macroscopic pictures of livers from control animals
and animals that have been injected with anti-CD40 72h before. B) Serum levels of the liver
specific enzyme ALT as measured by ELISA. C) Serum levels of the proinflammatory cytokines.
Serum was taken from C57BL/6 animals at the indicated timepoints after anti-CD40 injection
and analyzed using cytometric bead array. Statistic significance was analyzed using a One-Way-
ANOVA test.
5.2 Characterization of spleens from DC-LMP1/CD40
animals
To analyze the effects of a CD40 signal on DCs we generated DC-LMP1/CD40 mice in which
a CD40 signal is delivered specifically to cells which express CD11c (see also section 4.1.7).
These mice are born in mendelian ratios but are smaller then their littermates.
Since we wanted to analyze the influence of CD40 signaling in DCs in the context of
induction of tolerance and immunity we started our analysis by looking at the spleen as a
major site of induction of systemic immune reactions.
The architecture of the spleen of DC-LMP1/CD40 mice was largely intact (Fig. 5.3 A). B
cell zones and DC localization were unchanged in DC-LMP1/CD40 animals when compared
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to controls. No increase in extramedullary hematopoiesis, as indicated by Ter119 staining, was
detected. The anti-Ter119 mAb reacts with mature erythrocytes and some progenitor stages
of erythrocytes [100]. The number of lymphocytes per spleen on the other hand was strongly
reduced in all subsets analyzed, while at the same time a strong increase in granulocytes was
detected. Monocyte and pDC numbers remained unchanged (Fig. 5.3 B).
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Figure 5.3: Structure of the spleen is unchanged although the lymphocyte numbers
are reduced. A) Frozen sections of spleens from control as well as DC-LPMP1/CD40 animals
were stained for B cells (B220), DCs (CD11c) and erythrocytes (Ter119). Bars respresent 100
𝜇m. B) Cell numbers of different cell types in spleen.
To further investigate the influence of a CD40 signal specifically on splenic DCs, single cell
suspensions of spleens from control and transgenic animals were prepared and presence of
DCs as well as the subset distribution of CD8+, CD11b+ and double negative (DN) DCs was
analyzed (Fig. 5.4 B, C and D). We found that absolute number of DCs reduced in spleen.
This reduction was due to a decrease in the number of CD8+ DCs.
Next, we analyzed whether the CD40 signal leads to phenotypical and functional maturation
of DCs. To this end we analyzed the expression of MHCII as well as costimulatory molecules,
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both of which are upregulated on activated DCs. The expression of CD70, CD80 and CD86
was analyzed on the entirety of splenic DCs. There was no upregulation of CD70 and CD86
while CD80 was considerably upregulated compared to control animals (Fig. 5.4 E). Another
sign of DC maturation is the upregualtion of MHCII on the surface. However, the CD40
signal induces a significant downregulation of MHCII on the surface (Fig. 5.4 A).
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Figure 5.4: Splenic DC subsets and activation status. A) Representative FACS plots of
DCs in DC-LMP1/CD40 animals and statistics of cell numbers as representative results of one
of 4 experiments (n = 3 per experiment). B) Representative FACS-plots of splenic DC subsets
as differentiated by the expression of CD8 and CD11b. Plots are gated on live CD11c+MHCII+
cells. C) Relative amount of cells in the respective subset. Data pooled from two independent
experiments (n = 6). D) Number of cells in the respective subset. Data pooled from two
independent experiments (n = 6). E) Expression of costimulatory markers by splenic DCs,
representative results of 3 experiments (n = 3).
In order to functionally asses the capacity of DCs in DC-LMP1/CD40 animals to induce
tolerance, we made use of a T cell transfer-model. For this, transgenic T cells of known
antigen-specificity are transfered into recipient animals. They can then easily be followed
in vivo by looking at a congenic marker and can be functionally analyzed using the known
peptide to which the T cells react.
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To this end we purified and transfered OTI T cells into either control or DC-LMP1/CD40
animals. Control animals were left untreated or were injected with ovalbumin protein (Ova)
with or without additional anti-CD40 mAb. DC-LMP1/CD40 animals did only receive Ova.
If the CD40 signal would lead to a full functional maturation of DCs we would be able to
find proliferation of OTI cells without any further stimulus in DC-LMP1/CD40 animals and
these cells would also be able to kill target cells loaded with their cognate peptide.
Such an expansion of OTI cells was only observed in the case of control animals immunized
with Ova and anti-CD40 mAb. To a much lesser extend this was also seen in control ani-
mals that only received Ova, but not in DC-LMP1/CD40 animals (Fig. 5.5 A). To test the
functionality of the transfered OTI T cells, splenocytes loaded with the peptide recognized
by OTI and unloaded control splenocytes were transfered into the immunized animals at day
15 after immunization. After overnight incubation the specific lysis of these target cells was
analyzed. Killing was only observed for the animals that have received additional anti-CD40
mAb (Fig. 5.5 B). These findings indicated that DCs in DC-LMP1/CD40 animals were not
able to prime the transgenic OTI T cells. This might either be because the CD40 signaling
in DCs did not lead to a maturation status of DC sufficient to induce T cell responses or
because the CD40 signal induced changes that did not allow the DCs to take up or process
the protein antigen.
To make sure that the differences observed were not due to changes in the antigen-uptake
and -processing machinery in DC-LMP1/CD40 animals, we tested these capacities experi-
mentally. For this we injected a mixture of fluorescent AlexaFlour647-Ova and DQ-Ova into
transgenic and control animals. DQ-Ova is a fluorescent derivative of the Ova-protein, in
which the fluorescence is quenched and this quenching is relieved under acidic conditions e.g.
in lysosomes. It can therefore serve as a marker for antigen-processing. Two hours after inject-
ing this mixture, DCs in the spleen were analyzed. As shown in Fig. 5.5 C DC-LMP1/CD40
animals are able to take up and process antigen equally well or even better then wild type
control DCs.
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Figure 5.5: DC-LMP1/CD40 mice induce tolerance in CD8 T cells. OTI T cells
were transfered and their proliferation was analyzed after Ova protein injection. A) Kinetic
of OTI cell proliferation after injection of Ova. Cells were gated on live lymphocytes. B) At
day 15 after immunization CFSE labeled target cells loaded with peptide or control cells were
injected in animals of the different groups and specific lysis was analyzed 16 h later. C) Antigen
uptake and processing in live CD11c+MHCII+ cells was analyzed after intravenous injection of
AlexaFlour647-Ova and DQ-Ova. Animals were sacrificed two hours later and DCs analyzed for
fluorescence of AlexaFlour647-Ova (uptake) and DQ-Ova (processing). Representative plot n =
6.
Taken together, our results indicate that CD40 signaling in DCs does not lead to pheno-
typical or functional maturation. Instead we find immature DCs that are unable to induce
immune reactions.
In order to take a closer look at the changes, that the CD40 signal causes in DCs, we
performed gene expression analysis of more than 500 genes. To avoid effects caused by T
cell/DC interaction the analysis was performed in animals on the Rag−/−-background. We
compared DC-LMP1/CD40 animals to Rag−/− and in addition Rag−/− animals that had been
injected with anti-CD40 mAb 16 hours before DCs were sorted. This gave us the possibility
to compare the influence that a CD40 signal delivered by the transgene to the effects that
are observed when cells are targeted by anti-CD40 mAbs. For this, live CD11c+MHCII+ cells
were sorted from spleen, lysed and the mRNA copy number was analyzed using the nanostring
platform.
A principal component analysis was performed, to asses how similar the samples within
one group are to one another and to see how similar the different groups were. This analysis
clearly shows that all three experimental groups are distinct in their expression pattern from
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each other (Fig. 5.6 A).
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Figure 5.6: Gene expression of DCs from DC-LMP1/CD40 animals is more similar
to those from controls than DCs from animals injected with anti-CD40 mAb. DCs of
animals on the Rag−/− background were sorted based on high expression of MHCII and CD11c
and used for a nanostring gene expression analysis. A) Principal component analysis of the
different DC-groups. B) Expression of proinflammatory cytokines. Heatmap of genes that are
implicated in C) pattern recognition and associated signal transduction, D) antigen-uptake and
-presentation for MHCI as well as for MHCII and E) chemokines and chemokine receptors.
We further analyzed how the different CD40 signals influence the expression of mRNA
for proinflammatory cytokines. As shown in Fig. 5.6 B there was no induction of cytokine
transcription observed when transgenic DCs are compared to their wild type counterparts.
The only exception was a small increase in the levels of the anti-inflammatory TGF-𝛽. In
contrast, the injection of anti-CD40 antibody leads to a strong upregulation of IFN-𝛾, IL12-
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p40, IL1-𝛼, TNF-𝛼 and TGF-𝛽. The increase in TGF-𝛽 was also much stronger than in
transgenic DCs. IL12-p35 was hardly expressed at all under steady state conditions and was
also not induced by either way of CD40 signal delivery.
Next we looked at expression levels of genes that play a role in the detection of pathogens
and the corresponding signal transduction (Fig. 5.6 C). Here again the DCs treated with anti-
CD40 antibody showed a very different expression-pattern from the wild-type and transgenic
DCs. Most of the RNA were strongly upregulated after anti-CD40 injection with the exception
of mRNAs for toll-like-receptor (TLR)3, 5 and C1q binding protein (C1qbp). Transgenic DCs
on the other hand showed a remarkably similar expression pattern as compared to wild-type
except for C1qbp and TLR5, responsible for detecting the bacterial protein flagellin [101],
which are upregulated and TLR3, specific for double stranded DNA, which is downregulated
compared to wild-type.
Another important function of DCs is the processing of antigen and the subsequent loading
of these antigenic fragments onto MHC molecules. We also performed a cluster analysis with
genes playing roles in these processes and received similar results as with the previous two
groups of genes, namely more similarity between wild-type and transgenic DCs and clearly
a very different profile for DCs after stimulation with anti-CD40 antibody (Fig. 5.6 D). One
striking change was a strong upregulation of genes with a role in processing and loading onto
MHC class I molecules (Tap, Tapbp, 𝛽2m, proteasomal subunits) after antibody-treatment.
In contrast, the genes important for MHCII loading (e.g. CD74, H2-DMa, H2-DMb2) were
strongly downregulated after antibody treatment and were also slightly downregulated in
transgenic DC when compared to the wild-type. This is also mirrored in the MHCII protein-
expression levels (Fig. 5.4 A).
The last group of genes that we analyzed in more detail are chemokines and chemokine-
receptors expressed by DCs. Similar to the other genes, we also find DCs from DC-LMP1/CD40
animals being closer related to controls and less similar to anti-CD40 injected animals.
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5.3 DC-LMP1/CD40 animals develop spontaneous
colitis
As described above, DC-LMP1/CD40 animals were born in mendelian ratios but were visibly
smaller than their littermates. This was due to spontaneous development of colitis as shown
macroscopically by colon thickening and shortening (Fig. 5.7 A) or using fecal lipocalin-2 as a
non invasive marker for intestinal inflammation (Fig. 5.7 B) [102]. Disease could be detected
in four to five week old mice and its development could be prevented, when animals were
supplied ad libitum with a mixture of four different antibiotics (ABX), to deplete as much
of the commensal bacteria as possible. The same was true if the DC-LMP1/CD40 animals
were crossed onto a T and B cell-deficient background. This clearly showed that disease
development was dependent on the presence of bacteria as well as on cells of the adaptive
immune system.
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Figure 5.7: DC-LMP1/CD40 animals develop strong colitis, that is dependent on B
and T cells and commensal bacteria. A) Macroscopic pictures of colons from control and
DC-LMP1/CD40 animals on different genetic backgrounds or after administration of a mixture
of ampicilin, neomycin, vancomycin and metronidazol. B) Levels of fecal lipocalin-2.
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5.4 Influence of CD40-signaling on phagocytic cells in
the lamina propria of the colon
5.4.1 Mononuclear phagocytes in the lamina propria of
DC-LMP1/CD40 animals
Because of the described colitis, we went ahead and characterized the phagocytic cells of the
colonic lamina propria. In contrast to the spleen, macrophages of the gut are also positive
for CD11c and MHCII. Therefore, a more complex panel of markers is needed to investigate
and differentiate macrophages and DCs.
Single cell suspensions of lamina propria were stained for CD11c and MHCII and cells highly
positive for those molecules and negative for F4/80 or CD64, both markers for macrophages,
were analyzed for expression of CD11b and CD103. Using this panel one can distinguish
three DC subsets (Fig. 5.8 A). Of those, the frequency of the two CD103+ subsets is strongly
reduced in the DC-LMP1/CD40 animals on the wild-type background (Fig. 5.8 A). The
CD103+CD11b− cells are unchanged in numbers, while CD103+CD11b+ are reduced and
CD103−CD11b+ showed an increase in cellularity (Fig. 5.8 C).
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Figure 5.8: CD103+CD11b+ DCs are strongly reduced in the lamina propria of
DC-LMP1/CD40 animals. A) Representative FACS plots of DCs of the colonic lamina
propria from DC-LMP1/CD40 animals under steady state conditions. Cells were gated on
CD11c+MHCII+F4/80−. Numbers in FACS plots indicate percentage of DC subsets as mean ±
SEM (n = 9) B) Cell numbers show pooled results from two experiments (n = 6).
In order to find out if this reduction in CD103+ DCs is a secondary effect of the col-
itic inflammation or a direct effect of the transgene expression, we repeated this analysis
in animals that have been treated for three weeks with ABX or that were on the Rag−/−-
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background and therefore lacked inflammation. In both groups we found a decreased fre-
quency of CD11b−CD103+ and CD11b+CD103+ populations (Fig. 5.9 A). Also the absolute
numbers of CD103+ DCs were strongly reduced in DC-LMP1/CD40 animals on the Rag−/−
background and this tendency was also observed for CD11b+CD103+ DC in DC-LMP1/CD40
animals treated with ABX, although it did not reach statistical significance (Fig. 5.9 B). The
number of CD103− DCs was also increased in animals treated with ABX but to a much lesser
degree than in untreated animals. In animals on the Rag−/−-background we did not find an
increase in CD103− DCs.
Macrophages of the gut play an essential role in the homeostasis of the gut and at the
same time might express the LMP1/CD40 transgene due to some CD11c expression [103].
To further characterize if macrophages are changed in the transgenic animals, we used a
panel of markers developed in the lab of Bernard Malissen [38], allowing to differentiate
distinct developmental stages of Ly6Cℎ𝑖 monocytes from the moment they leave the circulation
(population P1 in Fig. 5.10 A) and enter the tissue until they finally become anti-inflammatory
macrophages (population P3/P4 in Fig. 5.10 A). Using this marker-set we could show that
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Figure 5.9: CD103+ DC reduction is independent of inflammation in DC-
LMP1/CD40 animals. A) Representative FACS plots of DCs of the colonic lamina propria
from DC-LMP1/CD40 animals on the Rag−/− background or after ABX-treatment. Cells were
gated on CD11c+MHCII+F4/80−. Numbers in FACS plots indicate percentage of DC subsets as
mean ± SEM from one of two independent experiments (n = 3). B) Representative cell numbers
of one of two experiments.
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in DC-LMP1/CD40 animals the percentage of cells in the "waterfall"-gate that fall into the
P3/P4 gate was significantly reduced compared to the wild-type controls. The overall cell
number on the other hand was strongly increased in all three subsets differentiated here. This
is due to the strong inflammation observed in DC-LMP1/CD40 animals which leads to an
overall increase in cellularity of the colon. To investigate the influence of the inflammatory
milieu we analyzed macrophages in ABX-treated animals as well as in Rag−/−-mice. After
ABX treatment we found the distribution of the three subsets unchanged as compared to the
wild type. In contrast, we also saw a reduction in P3/P4 in DC-LMP1/CD40 animals on the
Rag−/−-background. Taken together, this indicated that changes in macrophages observed
in untreated animals are due to the inflammatory milieu and not caused by the transgene
expression.
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Figure 5.10: Development of macrophages in DC-LMP1/CD40 animals. A) Gat-
ing strategy to analyze the development from Ly6Cℎ𝑖 monocytes towards tissue-resident
macrophages. B) Distribution of cells inside the "waterfall"-gate into the gates P1, P2 and
P3/P4 in untreated C57BL/6, ABX treated C57BL/6 and Rag−/−-animals (n = 3)
The absolute number of macrophages on the other hand was strongly reduced in both
5.4 Influence of CD40-signaling on phagocytic cells in the lamina propria of the colon 50
groups and in all subsets analyzed, although it did not reach statistical significance after
ABX treatment. This finding implicates that the reduction in the relative amount of P3/P4
might be dependent on a bacterial signal in addition to the CD40 stimulus and also hints at
a possible dependence of macrophages in the lamina propria on cells of the adaptive immune
system and commensal bacteria to properly differentiate.
Since we found a strong reduction of CD103+ DCs in the lamina propria of the colon and
these cells are known to migrate towards the draining lymph node, we analyzed DCs in the
mesenteric lymph node for the presence of the four DC subsets that can be differentiated in
this organ by CD103 and CD11b. We found a small reduction of the percentage of DCs inside
the live cell gate but this was compensated for by a larger number of living cells, so that the
final number of DCs per mLN was the same (Fig. 5.11 A). Again this was independent of the
proinflammatory milieu since we found the same in animals that were treated with ABX.
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Figure 5.11: CD103+ DCs are strongly reduced in mLN of DC-LMP1/CD40 animals.
A) Representative FACS plots of DC gate in mLN of control and DC-LMP1/CD40 animals with
and without ABX treatment and the statistics for these CD11c+MHCII+ cells. B) DCs from
A were analyzed using CD103 and CD11b. Number in representative FACS plots are mean ±
SEM (statistics for n = 10 untreated animals and n = 5 ABX treated ones).
Next we analyzed the DC subsets that can be found in the mLN and could indeed confirm
the results of the lamina propria. The CD103+CD11b− subset was reduced by about 60 %
when looked at the relative amount and 50 % when absolute cell numbers were considered
(Fig. 5.11 B). This reduction was even stronger in the CD103+CD11b+ compartment. Here
we found reductions between 70 and 80 %.
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All these results were again independent of an inflammation, since we found the same
in animals treated with ABX. Because we found the same numbers of DCs, defined as
CD11c+MHCII+ cells, but a reduction in both CD103+ populations, it is also to be ex-
pected that an increase of another subset would be detected. Indeed, this was the case for
the CD103− compartment, although it did not reach statistical significance.
Using the transgenic model, we were unable to differentiate if this reduction is due to
migration or cell death or both. To address this we made again use of the anti-CD40 injection
system.
5.4.2 Mononuclear phagocytes in the lamina propria after injection
of anti-CD40 mAb
Although the DC-LMP1/CD40 system has the advantage that one can directly deliver a CD40
signal to DCs without targeting other cells, at the same time it has the disadvantage, that it
is an "always-on"-sytem in which DCs receive the CD40 signal from the moment they express
CD11c. Therefore, it is difficult to define the first event in a cascade of events. To circumvent
this problem we utilized a system where the CD40 signal is delivered using anti-CD40 mAb
injection.
A kinetic was performed, where DCs in lamina propria and mLN were analyzed 16, 24
and 72 hours after antibody injection. We stained for the presence of all three different DC
populations and followed them over time.
In the lamina propria we could detect a decrease of all DC subsets as soon as 16 h af-
ter injection of the antibody. This decrease progressed until the end of the experiment and
no recovery in cell numbers was observed. At 72 h after injection there were hardly any
CD103+ cells left in the lamina propria and also the number of CD103− DCs was strongly
reduced(Fig. 5.12 A and B). This decrease was accompanied by an increase in CCR7 mRNA-
expression by CD11c+MHCII+ cells of the lamina propria already 16 h after anti-CD40 in-
jection as determined by nanostring expression analysis (Fig. 5.12 C).
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CCR7 expression could result in migration of DC from tissues to draining LNs [104]. Ac-
cordingly we could detect an increase in the the absolute number of all three DCs subsets in
the mLN (Fig. 5.12 A and B). This increase was transient, peaked at 24 h after anti-CD40
mAb injection and fell back to initial levels 72 h after injection.
This data suggest that CD40 stimulus of DCs induced an increased exit of DCs from the
lamina propria and a subsequent migration towards the draining lymph node.
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Figure 5.12: DCs decrease in lamina propria after anti-CD40 injection while they
transiently increase in mLN. A) CD11c+MHCII+CD64− cells were analyzed for the ex-
pression of CD103 and CD11b in lamina propria and mLN over 72 h after anti-CD40 injection.
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within the subsets defined in A) (n = 6 per group). C) Relative expression of CCR7 mRNA in
CD11c+MHCII+ cells of the colonic lamina propria from control and anti-CD40 treated animals.
To exclude that this effect was mediated by secondary effects of the mAb injection on other
CD40+ cells, we made use of a mouse-model in which CD11c-Cre cuts the floxed CD40-allel
(DC-CD40 KO mice), thereby rendering DCs CD40− and insensitive towards an anti-CD40
antibody. These animals were injected with anti-CD40 antibody and 72 h after injection
DCs of the lamina propria were analyzed for CD103 and CD11b expression. As shown in
Fig. 5.13 A CD103+ DCs were completely absent from the lamina propria of control animals
injected with the antibody, while the levels of CD103+ cells were basically unchanged in DC-
CD40 KO animals. This data shows that anti-CD40 mAb has to target DCs directly in order
to induce their exit from the lamina propria and is not mediated by secondary effects.
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Figure 5.13: CD103+DC reduction is dependent on CD40 expressed by DCs. A)
DC-CD40 KO animals and controls were injected with anti-CD40 mAb and three days later
lamina propria was stained for the presence of the different DC subsets (n = 5, pooled results
from two independent experiments).
Subsequently, we investigated the fate of DCs after they reached the mLN. To this end,
we performed flow cytometry based apoptosis assays in DCs isolated from the mLN of wild
type animals injected with anti-CD40 mAb either 16 h or 24 h before the analysis. Cells were
stained intracellular for active caspase 3, a late effector caspase essential for many apoptotic
pathways, and cells positive for this marker were considered to be apoptotic. The frequency of
apoptotic cells within the different DC subsets was largely unchanged (as shown in Fig. 5.14 A
and B). Contrary to this, the number of cells in a given subset for caspase3+ cells was strongly
increased 16 h after injection.
Since we found a shift in macrophage subset distribution in untreated DC-LMP1/CD40
mice (see Fig. 5.10), we also analyzed the distribution of cells within the waterfall gate,
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Figure 5.14: The number of apoptotic cells is increased in mLN after anti-CD40
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Representative FACS plots of active caspase 3 expression. B) Frequency of active caspase 3+ cells
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after we injected anti-CD40 antibody. We saw a transient increase in populations P1 and
P2, in percentage as well as in cells numbers. Parallel to that cells in the P3/P4 gate did
decrease transiently (Fig. 5.15). All population reached the initial level again at day three after
injection. This finding suggest that CD40 injection also influences macrophages and changes
the composition of macrophage-precursors and mature macrophages. If this influence is a
direct one or mediated by secondary effects remains unclear. But since macrophages have
been shown to be unable to migrate it is highly likely that they die in this setting [39].
In order to get an idea how the signal delivered by anti-CD40 antibody and the LMP1/CD40
transgene influences the gene expression in colonic mononuclear phagocytes, we performed
transcriptome analysis of CD11c+MHCII+ cells. For this, CD11c+MHCII+ cells were sorted
from the lamina propria of the colon. To avoid secondary effects due to the strong inflam-
mation on the normal C57BL/6 background, experiments were performed on the Rag−/−
background. Cells routinely had a purity of 85-95 % after sorting. In analogy to the DCs
from spleen, these cells were analyzed using the mouse immunology panel from NanoString.
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Figure 5.15: Number of mature macrophages decreases in lamina propria after anti-
CD40 mAb injection. Animals were injected with anti-CD40 antibody and the distribution
of cells in the three waterfall subsets was analyzed. A) Representative FACS plots of waterfall
cells (gated on live, CD45+, CD11b+ cells). B) Statistics of subset distribution. Data represents
one experiment (n = 3)
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Figure 5.16: Gene expression of mononuclear phagocytes in DC-LMP1/CD40 ani-
mals are different from those in control animals and animals injected with anti-CD40
mAb. Mononuclear phagocytes were sorted based on high expression of MHCII and CD11c and
used for a nanostring gene expression analysis. A) Principal component analysis of the different
groups. B) Expression of proinflammatory cytokines. C) Heatmap of genes that are implicated
in pattern recognition and the associated signal transduction. D) Heatmap of gene implicated
in antigen-uptake and -presentation for MHCI as well as for MHCII. E) Heatmap of chemokine
and chemokine-receptor gene expression.
A principal component analysis showed, that the CD11c+MHCII+ cells of the gut of DC-
LMP1/CD40 animals are highly different from those of control animals injected with anti-
CD40 mAb. The variance inside the antibody treated group is considerably higher than in
the spleen or in the other groups from the lamina propria, but the expression profiles of the
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samples still clusters together (Fig 5.16 A).
The cytokine expression profile for the lamina propria again showed no upregulation of
any proinflammatory cytokine for DC-LMP1/CD40 animals, but instead a downregulation
of IL1-𝛼 and IL1-𝛽 and additionally a substantial downregulation of the anti-inflammatory
molecules IL-10 and TGF-𝛽. The latter was also observed after antibody injection, where on
the other hand also an increase of IL6, IL12-p35 and -p40 was observed (Fig 5.16 B).
The expression of genes implicated in pattern-recognition is way more variable in phago-
cytes from the lamina propria than in those from spleen. In general we could observe an
upregulation of Tlr4, Ddx58 and Irf7 and a downregulation of Tlr1, -2, -8, -9 and Nod2 in
animals treated with anti-CD40 antibody, when compared to the wild-type. A downregula-
tion of Tlr2, -8, -9 and Nod2 could also be observed for phagocytes from transgenic animals.
Interestingly Tnfaip3, the gene coding for the protein A20 which is involved in regulating NF-
𝜅B signaling, was strongly downregulated in both transgenic and antibody-treated animals,
when compared to the controls (Fig 5.16 C).
In complete agreement with the results from the splenic DCs we found that the treatment
with anti-CD40 mAb led to the upregulation of the MHC class I machinery and the downreg-
ulation of the class II machinery. The latter is a feature shared between DCs from transgenic
and antibody treated animals (Fig 5.16 D).
The chemokine and chemokine-receptor expression differs from the other groups of genes
shown here in that we find more genes that are regulated the same way in transgenic animals
and wild type controls injected with anti-CD40 antibody. Most of these genes are down-
regulated (Ccl3, -4, Ccr5, Cxcl10 and Cmklr1). The notable exception from this rule is the
expression of CCR7 that is induced in both groups of CD40 stimulated phagocytes. In ad-
dition to this, anti-CD40 stimulated phagocytes also show upregulated expression of Ccl2, -5
and Cxcl11 (Fig 5.16 E).
In summary, gene expression of phagocytic cells from the GALT of DC-LMP1/CD40 an-
imals differ considerably from DCs in control animals with or without anti-CD40 injection.
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Interestingly though, we were unable to observe production of proinflammatory cytokines in
DC-LMP1/CD40 animals in the population of cells analyzed here.
5.5 Effector mechanism of colitis in DC-LMP1/CD40
animals
Experiments in which DC-LMP1/CD40 animals were crossed onto the Rag−/−-background
and thereby eliminating the influence of B and T cells showed that the development of colitis
was dependent on either one or both of these cell types. To further study the role of adaptive
immunity in disease development we looked at antibody and T cell responses.
5.5.1 Bacterial reactive antibodies
Serum was taken from DC-LMP1/CD40 animals of different ages and used as a primary
antibody in an ELISA. The ELISA plate was coated with a homogenate of cecal contents
from healthy C57BL/6 mice, therefore containing bacterial- as well as food-antigens. Isotype-
specific antibodies were used as secondary antibodies, to be able to differentiate the isotype
reacting to the antigens.
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Figure 5.17: Serum of DC-LMP1/CD40 animals shows reactivity towards cecal
contents. Cecal bacterial lysates were coated onto an ELISA-plate and serum from mice of
different ages was used as primary antibody in an ELISA (n =3-5).
As shown in Fig. 5.17 we found an increase in reactivity against commensal antigens in
animals older then 7 weeks. This reactivity was confined to antibodies of the IgG1 and
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IgA isotype. Additionally, we showed that the treatment of these animals with ABX led
to the absence of reactivity towards the commensal antigens in the serum of these animals,
suggesting that rather bacterial than food-antigen was recognized by these mAbs.
5.5.2 Regulatory T cells
Because of the well established connection between CD103+DCs and Treg generation [48, 49],
we decided to look in detail into the Treg compartment of DC-LMP1/CD40 mice. Tregs were
defined as CD4 T cells with high expression of FoxP3 as well as a varying expression of CD25.
Using this gating strategy we found no differences between control and DC-LMP1/CD40
animals in the frequency of Tregs in the CD4 T cell compartment in spleen, mLN or the
lamina propria (Fig. 5.18 A).
We next employed a staining scheme that has been developed by Caspar Ohnmacht in the
lab of Gerad Eberl [71], that allowed us to differentiate thymus-derived Tregs (nTregs) from
Tregs that have been induced in the periphery (iTregs). As shown in Fig. 5.18 B one can
distinguish two populations within the FoxP3+ population when using the markers Helios and
ROR𝛾t. nTregs are Helios+ROR𝛾t− and iTregs are Helios−ROR𝛾t+. In wild type animals
between 60 and 80% of Tregs in the lamina propria of the colon are iTregs. In DC-LMP1/CD40
animals this population is virtually absent and all Tregs are thymus-derived nTregs.
This finding was recapitulated in a model were OTII cells were transfered into control
and DC-LMP1/CD40 animals and these were fed with ovalbumin in drinking water for five
days. Antigen delivered by the oral route usually leads to the induction of tolerance. In fact,
this can be observed in the wild type control were we find a substantial induction of FoxP3
expression in the OTII population in the mLN. In DC-LMP1/CD40 animals on the other
hand, this population of FoxP3+ OTII cells was almost absent, again showing a strong defect
in Treg induction (Fig. 5.18 C).
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Figure 5.18: Tregs are present at normal frequencies in all organs, while iTregs
are missing. A) Representative FACS-plots of Treg stainings in the lamina propria of control
and DC-LMP1/CD40 mice. Cells are gated on live CD3+CD4+ cells (top row). Bottom row
shows representative statistics of one of at least two experiments for Tregs in the indicated
organs (n = 3). B) Tregs found in the lamina propria of the colon were further subdivided
into nTregs (Helios+ROR𝛾t−) and iTregs (Helios−ROR𝛾t+). Representative result of one of
three experiments (n = 3) C) OTII cells have been transfered into control and DC-LMP1/CD40
animals that have been treated with ABX for 4 weeks and these animals were given ovalbumin
in drinking water for 5 days. The expression of FoxP3 was analyzed in OTII cell recovered from
mLN. Representative result of one of three experiments (n = 3)
To test if the observed lack of Treg induction was dominant, we generated mixed bone
marrow chimeras of wild type and DC-LMP1/CD40 bone marrow that could be differentiated
using CD45.1 and CD45.2 respectively. To make sure that we did not transfer cells that have
been primed in a colitogenic environment and thereby transfer cells that in turn might have
an influence on the DCs or disease development, we transfered DC-LMP1/CD40 bone marrow
of animals on the Rag−/−-background.
We did not observe any visual signs of colitis in any of the chimeras. To look at a cellular
level we characterized DCs in lamina propria and mLN and also stained for Tregs in the gut.
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Figure 5.19: iTregs can be induced in mixed bone marrow chimera. A) Representative
FACS-plots of DC subsets from lamina propria and mLN of both types of chimera. Cells are
gated on live CD11c+MHCII+F4/80− cells (top row). Statistics are shown for n = 6, number
in FACS plots indicate mean ± SEM. B) Representative FACS plots of FoxP3+ Tregs found in
the lamina propria of the colon further subdivided into nTregs(Helios+) and iTregs (Helios−).
Statistics for n = 6.
In the chimeric setting the DC-LMP1/CD40 bone marrow gave rise to reduced levels of
CD103+ DCs in the lamina propria, while CD103− DCs were present at normal frequencies
and numbers. DCs derived from the wild type bone marrow, co-transfered into the same
animals, reached comparable levels to those from the control chimera (Fig. 5.19 A upper
row).
Interestingly, in mLN all DCs derived from DC-LMP1/CD40 bone marrow are strongly
reduced when compared to DCs derived from the co-transfered wt bone marrow or to the
numbers observed in the wt/wt chimera. Although within the DC-LMP1/CD40-derived DCs
we find frequencies of CD103+CD11b− and CD103− DC comparable to those from wt-derived
DCs, the overall number of DCs derived from DC-LMP1/CD40 bone marrow in mLN is lower.
This indicates a strong disadvantage of DCs derived from DC-LMP1/CD40 animals compared
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to the wt-derived DCs.
Nevertheless, we could use this model, in which we had CD103+ DCs derived from normal
and transgenic bone marrow side by side in one animal, to investigate if the suppressive
influence of transgenic DCs on the development of iTregs is dominant. For this the lamina
propria of both mixed chimera was stained for the presence of Tregs and these were then
classified as iTregs (Helios−) and nTregs (Helios+). Using this scheme we could show that
there was normal induction of Tregs in the periphery of mixed bone marrow chimera also in
animals that received a mixture of wt and DC-LMP1/CD40 animals.
Therefore we concluded that the lack of iTregs in DC-LMP1/CD40 mice was not a dominant
effect caused by the transgenic DCs, but rather caused by lack of appropriate DCs, needed
for iTreg induction.
5.5.3 Th1 and Th17 cells
In order to investigate the fate of T cells in DC-LMP1/CD40 we performed ex-vivo T cell poly-
clonal restimulations of T cells from the lamina propria and mLN with phorbol-12-myristat-
13-acetat (PMA) and ionomycin. The cells were then stained intracellularly for the presence
of Il-17 and IFN-𝛾.
In lamina propria of DC-LMP1/CD40 animals higher frequencies of IFN-𝛾+ and IFN-
𝛾+IL17+ producing T cells were found. At the same time the frequency of IL-17+ T cells
was unchanged (Fig. 5.20 A). The absolute cell numbers of all these subsets were increased in
DC-LMP/CD40 animals (Fig. 5.20 B). This increase was due to the strong increase in overall
cellularity due to the inflammation.
In mLN only the IFN-𝛾+IL17+ T cells were increased while both other subsets remained
unchanged in frequency and cell numbers (Fig. 5.20 A and B).
This clearly shows that T cells in the lamina propria are more activated than their control
counterparts and also indicates that the response takes place in the lamina propria itself rather
then in the draining lymph nodes. This is another indication that the antigens recognized
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by these T cells can be found, similar to the antigens recognized by the mAbs described in
section 5.5.1, rather in the gut than elsewhere.
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Figure 5.20: DC-LMP1/CD40 animals show increased levels of proinflammatory T
cells in the lamina propria. A) Representative FACS-plots of IL-17 and IFN-𝛾 production
by T cells of lamina propria and mLN. Cells are gated on live CD3+CD4+ cells. B) Frequency
of T cells secreting IL-17 or IFN-𝛾 or both. C) Absolute numbers of T cells secreting IL-17 or
IFN-𝛾 or both. (always n = 3)
6 Discussion
The influence of CD40-signaling on DCs is still not fully understood and literature is contro-
versial on the question to what degree a CD40 signal leads to phenotypical and functional
maturation of DCs (see page 17). Here we were able to investigate the role of a CD40 signal
delivered by an antagonistic antibody in DC maturation and function. Additionally, we also
developed a system in which DCs receive a ligand-free CD40 stimulus, which let us analyze
the effect of CD40 in DCs without the effects, that an antibody has on other cell types.
Using this system we were able to show very different effects of such a signal on DCs in
various locations. DCs in spleen largely remained unchanged in phenotype and function, while
DCs of the GALT showed major changes in subset distribution and function. These shifts,
in the end, also led to the development of severe colitis in animals expressing the transgene.
6.1 Anti-CD40 mAb injection causes liver inflammation
independent of B and T cells
The injection of anti-CD40 antibody led to strong liver inflammation in B and T cell suffi-
cient wild type animals as can be seen by increased serum level of alanine amino transferase
(Fig. 5.2). This inflammation, with its secondary effects, very much limits the value of the
information regarding the influence of CD40 signaling on DCs. These findings, on the other
hand, are in line with previous publications concerning anti-CD40 injection into wild type
animals by the group of Francis Chisari [88].
Contrary to published results, though, we could also observe increased sALT levels accom-
panied by macroscopically visible inflammation in the liver even in Rag−/− animals (Fig. 5.2 A
and B). Previously, the damage in the liver has been attributed to the presence of B cells in
the liver that get activated by the anti-CD40 antibody because this inflammation was not
observed in SCID animals, but could be found after B cells from wild type were transfered
6.2 DC-LMP1/CD40 animals develop colitis 64
into SCID animals [88].
Our results strongly argue against a role for B cells in CD40 mAb-induced liver inflamma-
tion, contrary to previous studies [88]. On a cellular level there is no difference observable
between Rag−/− and SCID animals, both are lacking all mature B and T cells. It is possible
that other influences, that have not been controlled for might play a role. In the end it is
unclear how these differences can be explained but our data suggests that the effects leading
to liver inflammation are independent of adaptive immunity. The inflammation is more likely
mediated by other cells expressing CD40 such as epithelial or endothelial cells.
The injection of anti-CD40 mAb also causes a cytokine storm (Fig. 5.1 C), characterized by
rapidly increasing serum levels of MCP-1, TNF-𝛼, IFN-𝛾 and Il-6. The increase is transient
and peaks already between 16 and 24 h after injection. And while DCs are in principle able
to produce TNF-𝛼, IFN-𝛾 and IL-6 [105, 106] and they have also been shown to be produced
after CD40 ligation [82], it is not possible to differentiate the source of this cytokine storm
after antibody injection. IL-6 for example can also be produced by B cells after CD40 ligation
[107].
Another problem complicating the interpretation of the data gathered using antibody in-
jection is, that many of the cytokines have a direct role in DC biology. For example MCP-1
is a chemoatractant and TNF-𝛼 can change expression of costimulatory molecules [55]. This
makes it impossible to distinguish between primary effects, caused by the mAb acting on DCs
and secondary effects, caused by cytokines secreted by other cells and thereby limits the use
of anti-CD40 mAb injection in vivo to investigate its role on DCs.
6.2 DC-LMP1/CD40 animals develop colitis
In order to circumvent the off target problems when using anti-CD40 antibody, we generated
a mouse that expresses a constitutive active CD40 molecule under the control of the CD11c
promotor.
These DC-LMP1/CD40 animals developed severe colitis early on in life as indicated by
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swelling and shortening of the colon and by increased levels of lipocalin-2. Lipocalin-2 was
shown to be a reliable, non invasive marker for intestinal inflammation, which in addition, was
also a quantitative indicator, as shown in a model of dextran-sodium sulfate-induced (DSS)
colitis [102]. Using this marker, we could show that disease development was dependent on
the presence of T and B cells as well as on commensal bacteria (Fig. 5.7).
The commensal dependency of disease development found in our study is in line with the
role of bacteria in other colitis models. It has independently been shown for many of the
commonly used colitis mouse models, like the DSS-induced colitis [108], the T cell transfer
colitis [109] and for colitis caused by IL-10−/− [110], in all of which disease could not be
induced in the absence of bacteria in the intestine.
This protection from colitis by bacterial depletion was mostly attributed to the absence of
bacterial antigen that T cells can react to [109].
There are also examples of commensal bacterial strains which are capable of inducing
intestinal pathology under certain conditions, like changes in the environment or the presence
of genetic factors. One example of this is segmented filamentous bacteria (SFB), a bacterium
that has to be present in SCID-animals to develop colitis after transfer of CD4+CD45RB+
cells [111]. Another example of a bacterial strain causing colitis is helicobacter hepaticus
which is essential for disease development in a T cell transfer colitis model [112].
A role for T cells in intestinal pathology has been demonstrated in a model of induced
colitis in which T and B cell deficient animals receive naïve effector T cells and subsequently
develop wasting disease and show histological signs of colitis [113].
Therefore, the dependence of colitis development on bacteria and adaptive immunity ob-
served in DC-LMP1/CD40 animals is well in line with results from other colitis models. Ad-
ditionally, it fits well to a model where loss of tolerance and concomitant priming of adaptive
immunity to commensal derived antigens caused colitis.
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6.3 In a sterile environment LMP1/CD40 signaling
produces tolerogenic DCs
We started the characterization of the DC-LMP1/CD40 animals by looking at cells in the
spleen. Because of previous work showing that a CD40 signal, without additional stimuli
does not cause full maturation of DCs [85, 86, 87], we expected to find DCs that are largely
unchanged in their phenotype and function in the sterile environment of the spleen, where
DCs, in contrast to the colon usually have no contact with bacteria.
The overall architecture of the organ was still largely unchanged in DC-LMP1/CD40 an-
imals, with intact T and B cell zones, DCs located in the marginal zone and in the T cell
zones. Interestingly, in DC-LMP1/CD40 animals we found, in spite of the normal spleen ar-
chitecture, a strong decrease in all lymphocyte cell types and on the other hand an increase in
granulocytes. This is an indication that the inflammation, observed in the gut (see discussion
below) might also spread to other organs. This effect is probably mediated by changes in
serum cytokine levels, as described by Stefanie Meier [115]. Proinflammatory cytokines were
found to be upregulated in this study, which might be part of the reason for an increased
granulocyte recruitment or granulopoiesis in spleen.
A detailed DC subset analysis in the spleen revealed a relative increase of DN DCs in DC-
LMP1/CD40 animals (Fig. 5.4). However, this did not hold true for absolute number. The
analysis of numbers instead revealed a decrease in CD8+ DCs.
Of all costimulatory molecules tested we only observed a moderate upregulation of CD80
on DCs of transgenic animals (Fig. 5.4 E). In addition to this being the only upregulated cos-
timulatory molecule, CD80 has recently been implicated not just in costimulatory activities,
via CD28 interaction, but also shows coinhibitory potential by interacting with B7-H1 [116].
This complex interaction of CD80 makes it difficult to asses the outcome of such a slight
upregulation and does not rule out the potential of DC-LMP1/CD40 DCs to still induce
tolerance.
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The fact that we were also unable to find any indication of upregulated signal 3 by DCs
from DC-LMP1/CD40 spleen, which is needed for a productive T cell activation further
raised the possibility that DCs are capable of tolerance induction. CD70 was unchanged in
comparison to the controls and so were the typical proinflammatory cytokines like IL12 and
IL6 (Fig. 5.4 E and Fig. 5.6 B). The lack of IL-12 secretion is in agreement with the work of
Caetano Reis e Sousas lab [87]. He showed that a CD40 stimulus, delivered via antagonistic
mAb, alone fails to induce IL-12 production but that a bacterial stimulus has to be present,
which is missing in spleens.
Most importantly, we were able to show, in a T cell transfer model, that DCs in DC-
LMP1/CD40 animals are not activated in a way that would allow them to prime T cells
without any further stimulus (Fig. 5.5). DC-LMP1/CD40 animals were unable to induce any
expansion of the transfered CD8+ T cells and did also not induce any cytotoxic activity in
these T cells.
Taken together this clearly shows that DCs in the spleen of DC-LMP1/CD40 animals do
not reach an activation state that would allow them to prime and propagate a T cell response
without any additional stimulus. The injection of anti-CD40 antibody on the other hand
shows the expected, strong adjuvant effect [73], that allows for T cell expansion and cytotoxic
activity.
Interestingly the expansion of T cells in the DC-LMP1/CD40 animals is even significantly
reduced compared to control animals, when both groups only received Ova. To rule out that
this was due to a reduced capacity in antigen-uptake or -processing, we compared the two
parameters by injecting different flourescent variants of Ova. Using these we could clearly
show that the uptake, as indicated by MFI of AF647-Ova in DCs, and processing, indicated by
MFI of DQ-Ova, was not different between the two genotypes. One drawback of the DQ-Ova
system is, however, that it only indicates degradation of the Ova in an acidic compartment
[117]. This of course leaves open the question of the subsequent fate of the antigen. And
one has to consider that the number of CD8+ DCs in the spleen was strongly reduced and
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this subset is the one, that is able present peptides from extracellular protein especially well
onto MHCI molecules (cross presentation) [118]. If one takes into account that the amount
of T cell expansion is higher in DC-LMP1/CD40 animals, when immunized with the peptide
recognized by OTI [115], it is very likely that the weaker expansion after protein immunization
is due to the changed subset distribution and the resulting reduction in cross-presentation
capacity.
Overall we were able to show that a sterile CD40 signal, selectively delivered to DCs, does
not cause full maturation of these cells. This is not just shown by phenotypic markers but
also by the retained capability to induce tolerance in a transfer model.
6.4 Influence of CD40 on phagocytic cells in the GALT
Because of the strong intestinal inflammation in DC-LMP1/CD40 animals we character-
ized the phagocytic cells of the GALT. For this we differentiated DCs into three subsets on
the basis of CD103- and CD11b-expression. Using this set of markers one can distinguish
two CD103+DC subsets in the lamina propria itself, of which one expresses CD11b and the
other one does not. Additionally, there is a subset expressing CD11b but not CD103. In
DC-LMP1/CD40 animals the frequency of CD103+ cells was strongly reduced, while the
CD11b+CD103− cell were relatively increased.
6.4.1 Anti-inflammatory Macrophages
The CD103−CD11b+ cells found inside the CD11c+MHCII+ population, represent mostly
macrophages and their precursors. To further analyze them we used a staining panel that
allowed us to follow the development from monocytes, that recently extravasated from blood
into the tissue, to mature macrophages [38]. We could show a reduction in the frequency
of mature macrophages in the gate P3/P4 in DC-LMP1/CD40 animals (Fig. 5.10 B). This
reduction was also observed in transgenic animals on the Rag−/− background but not after
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depletion of bacteria by ABX. This indicates that the decrease is independent of proinflamma-
tory cytokines and driven by the CD40 signal itself with an additional bacterial-derived signal.
This idea is further strengthened by the notion that also after anti-CD40 mAb injection we
see a strong, but transient, decrease in populations P3/P4.
Again, because of the strong increase in cellularity, we find higher numbers of all three
subsets in untreated DC-LMP1/CD40 animals, although the relative increase is lowest for
the subsets P3/P4. Interestingly, the numbers of macrophages are strongly reduced in all
three population in ABX and Rag−/− mice, although it did not reach statistical significance
in ABX treated animals. Since this reduction is observed under both non inflamed conditions,
one conceivable explanation is a necessary cross talk with DC subsets which are reduced under
both these conditions. Another possibility would be a direct influence of the transgene, that
might be expressed at least in some subsets.
P3/P4 is a heterogeneous population, which could be further divided into a CX3CR1𝑚𝑒𝑑-
and a CX3CR1ℎ𝑖𝑔ℎ-fraction [37, 38]. This differentiation can only be made using reporter
animals for CX3CR1 gene expression, because the available antibodies do not have an affinity
high enough to distinguish between those two populations.
Populations P3 and P4 are not just phenotypically different but they also differ in their
functional profile. Cells within P4 are macrophages that are insensitive towards TLR stim-
ulation, even under colitogenic conditions. In comparison to that one sees an increase in
responsiveness towards LPS in P3 cells, when colitis is induced [37].
The reason for the relative reduction of cells in P3/P4 is unclear, but since the P4 cells
are partially positive for CD11c and also a subfraction of P3 cell shows CD11c expression,
a direct influence of LMP1/CD40 signaling on these cells can not be completely ruled out.
In fact in CD11c-Cre x ROSA-RFP animals one can detect a RFP signal in cells that are
Ly6C− within the waterfall (data not show). These cells would correspond to P3 and P4 cells
in the waterfall staining. Since RFP and LMP1/CD40 are knocked into the same locus and
the stop-cassette is removed by the same Cre, it is likely that we also see some transgene
expression in P3 and P4. Although it is unclear whether this in turn leads to the decrease in
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P3 and P4 cells or if this is mediated by other mechanisms.
In favor of a direct influence of CD40 signal on these populations is also the data gained
by using the anti-CD40 antibody. Here also the numbers of P3/P4 cells drops shortly after
injection, while cell number for P1 and P2 increase transiently. Since these cells follow an
ordered sequence of differentiation steps, it is likely that cells in P3 and P4 disappear and
this in turn leads to an increased influx of Ly6Cℎ𝑖 monocytes that in the end fill up the niche
left open. Because macrophages in the lamina propria are derived from monocytes this niche
is filled up quickly. Monocytes are readily available in the circulation and are able to replace
the macrophages within 72 hours as show by adoptive transfer experiments [38].
In addition to the reduction in P3/P4 we did also find significantly more cells in P1 and
P2 in DC-LMP1/CD40 animals during colitis and the increase in cell number is relatively
higher than the increase in P3/P4. This finding is completely in line with a reported break
in the development from Ly6Cℎ𝑖 monocytes towards the anti-inflammatory macrophages dur-
ing intestinal inflammation [37]. Accordingly, this increase in cell numbers for P1 and P2
macrophages was not observed in animals after ABX treatment or on the Rag−/−. Cells in
the P2 gate are not yet fully adapted to an anti-inflammatory role in the gut and do still
respond to TLR-ligands and produce inducible nitrite oxide synthase (iNOS), TNF-𝛼 and
IL-23 [37, 38, 119]. Via these mechanisms cells in P2 might help support colitis development.
A role in the initiation of disease on the other hand seems unlikely, since the cells are not
able to express the transgene, due to a lack of CD11c expression.
6.4.2 Influence of CD40 signaling in CD103+ DCs
Injection of anti-CD40 antibody in both C57BL/6 and Rag−/− animals led to a strong decrease
of all DC subsets in the lamina propria of these animals (Fig. 5.12). Contrary to that, in
DC-LMP1/CD40 animals we found a selective reduction of CD103+ DC subsets (Fig. 5.10).
In contrast to that, we found an increase in the frequency of the CD103−CD11b+ DCs subset.
If colon of non-inflammed animals was analyzed, we could still find a reduction in frequency
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of CD103+ DCs, which then was also mirrored in reduced numbers of CD103+ DCs, with
the exception of the CD103+CD11b− subset in the ABX treated animals. In untreated
and ABX-treated animals these reduction was also seen in the gut draining mLN. Thus we
observed an overall decrease of CD103+ DC in the GALT of animals that received a CD40
stimulus. CD103− DCs show the same pattern after anti-CD40 injection but not in the
transgenic animal, where the constant pro-inflammatory milieu probably leads to changes in
recruitment and replenishment of this more heterogeneous subset.
Furthermore, using the DC-CD40 KO mouse model we were able to show that the absence
of CD103+ DCs after anti-CD40 mAb injection was directly caused by the influence of the
antibody on the DCs and not by any side effects caused by the cytokine storm or the liver
inflammation.
Hence, we were able to use the antibody injection model to further elucidate what happens
to DCs after CD40 stimulation. We could show that already 16 h after injection the frequency
and number of all DC subsets were decreasing in the lamina propria, while at the same time
frequency and numbers were increasing in the mLN. This was accompanied by an increase
in CCR7 expression in CD11c+MHCII+ cells in the lamina propria 16 h after injection. And
although this population also contains a big proportion of macrophages, these cells are highly
unlikely to be responsible for the increase in CCR7 message, since they have been shown to
be sessile and unable to migrate under physiological conditions [39].
Taken together this data strongly suggest that a CD40 signal in DCs of the lamina propria
induces them to migrate towards the draining lymph node. This phenomenon has been
described before, although in the work of Persson et al. [29] this migration was only observed
for CD103+CD11b+ subset and only after injection of anti-CD40 and LPS. Contrary, we
observed a migration of all DC subsets after anti-CD40 injection alone. These differences
might be explained by a differential colonization of these animals with microbiota. On the
other hand we also observed this migration also in animals after ABX treatment. But a role
of bacterial-derived signal still can not be ruled out completely, since the depletion of the
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microbiom is, although very efficient, still incomplete.
The described migration of DCs to the mLN on the other hand is just transient and
apoptosis assays showed that in parallel to the increase in number of DCs also the number
of cells undergoing apoptosis was increased (Fig. 5.14). In contrast, we did not find any
indication of an increase in the rate of apoptosis after anti-CD40 antibody injection. However,
there have been reports, that the opposite is the case and that CD40 in the immunological
synapse can inhibit apoptosis via Akt1 activation [120]. The process of apoptosis is normal
for DCs and helps to limit the time that an antigen is presented by activated DCs and has
even been implicated in tolerance induction [121].
The situation is of course different in DC-LMP1/CD40 animals. Here the CD40 signal is
given to the DCs as soon as they upregulate CD11c and thereby also activate Cre-recombinase.
Because of this we were unable to find an early migration followed by cell death, but instead
we are looking at a changed equilibrium between cells in gut and mLN. We still found a strong
reduction of CD103+ DCs in the lamina propria, but in addition also CD103+ subsets in the
mLN are reduced, with the CD103+CD11b+ being stronger reduced then the CD103+CD11b−
subset. In addition we also observed a strong increase in CD103−CD11b+ DCs in the lamina
propria of untreated and ABX-treated animals. These cells, although CD11b+, are probably
not inflammatory DCs, because those have been reported to be also positive for F4/80 and
CD64 and all cells considered to be lamina propria DCs in this work, have been defined as
negative for F4/80 and CD64. The increase might instead be explained by compensatory
mechanisms that step in due to the long lasting change in DC function and the resulting
inflammation.
All this clearly points out that CD40 signaling induces migration of CD103+ DCs into the
draining lymph node were the cells die not long after they arrive. And while DCs constantly
migrate from tissue into draining lymph nodes, the application of anti-CD40 mAb greatly
increases migration and DCs migrate earlier then they would have under normal steady-state
conditions.
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6.5 Comparative transcriptome analysis of DCs after
CD40 stimulation
In order to analyze the maturation status of DCs after CD40 signaling and to compare the
different influences of a CD40 signal derived from the transgene with those from the anti-CD40
antibody, a gene expression analysis was performed. Animals on the Rag−/− background were
used since the inflammatory environment in animals on the wild type background induced
strong secondary effects that confounded the analysis (Ferdinand Simon, unpublished results).
The study focused on CD11c+MHCII+ cells from spleen and lamina propria.
A principle component analysis indicated on a general level that the expression of DC-
LMP1/CD40 DCs is very different from the pattern found after anti-CD40 antibody injection.
This is even more pronounced when the profile of DC-LMP1/CD40 DCs in the spleen was
analyzed for transcripts especially important for DC biology, such as antigen uptake and
processing or pattern recognition, which are largely unchanged compared to the wild type
(Fig. 5.6). At the same time this also indicates that many changes observed after anti-CD40
mAb injection are either indirect effects of the antibody on DCs or that the strength of the
signal received by DCs might differ. The outcome in any case is a much more proinflammatory
gene expression profile, characterized by high levels of IFN-𝛾, IL-1𝛼 and TNF-𝛼 in DC from
animals treated with anti-CD40 mAb when compared to DC-LMP1/CD40 DCs.
For the interpretation of the gene expression data from the lamina propria one has to keep
in mind that a cell isolation on the basis of CD11c and MHCII expression leads to distinct
mixtures of DC and macrophage subsets from different mice. In the case of wild type animals
this yielded a mixture of DCs and macrophages, while after CD40 stimulation we did not
find a lot of DCs but were left almost exclusively with macrophages. Consequently we were
comparing not just expression of DCs under different conditions to one another but different
mixtures of heterogeneous cell populations.
But even under this conditions the expression pattern found in cells from DC-LMP1/CD40
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animals clearly differed from the cells sorted after anti-CD40 mAb injection (Fig. 5.16).
Phagocytes from the lamina propria also showed an increase in certain proinflammatory
cytokines, such as IL-12 and IL-6, after anti-CD40 antibody injection, but more importantly
the amount of transcripts for anti-inflammatory cytokines was dramatically decreased. The
main source of IL-10 in the CD11c+MHCII+ cell fraction from lamina propria are macrophages
of the P4 population [37], which were strongly reduced in both CD40 models. TGF-𝛽 is also
downregulated in both CD40 treated groups, although not as strongly as IL-10. TGF-𝛽 has
been shown to be produced by macrophages [122], as well as by CD103+DC, a cell type which
is absent from these samples [48].
Interestingly we were not able to find any signs of DC activation in cytokine gene expression
levels for the transgenic animals, neither in spleen nor in lamina propria. For splenic DCs this
is completely in line with our finding of a more tolerogenic DC phenotype in this organ. DCs
from the GALT on the other hand might be expected to show a more activated phenotype.
Although we were unable to find clear indication of DC activation in the expression analysis
of DCs from the lamina propria of DC-LMP1/CD40 animals, this does not necessarily mean
that the transgene does not lead to such an activation. The sort of such a heterogeneous
population only captures a certain timepoint and of course also only the cells that remain in
the organ. When we consider the fast kinetics of CD103+ DCs leaving the lamina propria after
anti-CD40 mAb injection, we can assume that cells which received the signal will already have
left the lamina propria and consequently do not have an influence on the expression profile.
In order to circumvent this one would have to analyze DCs arriving at the mLN, which is
difficult in Rag−/− animals where secondary lymphoid structures do not form correctly [96].
An especially interesting cluster of genes is the one containing molecules implicated in
processing and loading of MHC class I and II molecules. Anti-CD40 mAb injection causes a
strong upregulation of molecules of the MHCI loading and processing machinery in DCs from
spleen and lamina propria, while the LMP1/CD40 transgene has no detectable effect on this
cluster of genes. Interestingly, molecules with a role in MHCII antigen processing, loading and
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presentation show lower expression in both CD40-groups. This effect was more pronounced
in the lamina propria but could also be observed in splenic DCs. In the end these changes
could also be observed on protein levels with a lower MHCII expression per cell detectable
in all tissues. In contrast mature DCs show higher expression of MHCII molecules on the
surface [123], a finding arguing for a more immature state of DCs after CD40 stimulation.
In spleen, the gene Tnfaip3 (A20) was strongly upregulated after anti-CD40 mAb injection
and still showed an substantial upregulation in transgenic DCs. DC-specific A20 knock-out
animals showed a spontaneous maturation of DCs that finally led to fatal autoimmunity
[114, 124]. These studies underlined an important role of A20 in the downregulation of
receptor signaling pathways from molecules like TLRs, Nod2 and also CD40. A20 shuts off
NF-𝜅B signaling by removing activating ubiquitinations and at the same time adds ubiquitins
to sites that mark proteins for degradation [125]. It seems plausible to assume that an
increase in the expression of Tnfaip3 is caused by increased NF-𝜅B signaling, caused by CD40
signaling, especially since in B cells the transgene LMP1/CD40 has already been shown to
signal in part via NF-𝜅B [90]. The observed increase in Tnfaip3 expression would pose a
possibility to counteract the increased signal a DC receives via CD40.
Interestingly, a set of genes that are upregulated by splenic DCs in transgenic animals
but not after anti-CD40 mAb injection comprises the chemokine receptors CCR6 and CCR9.
Both receptors are important for DCs to home towards the gut [126]. This might be indicative
of a cytokine milieu inducing migration of DCs towards the site of inflammation.
Overall the gene expression profile of DC-LMP1/CD40 DCs is in many key aspects of
DC biology unchanged when compared to wild type DCs. This is in stark contrast to DCs
after CD40 mAb injection, causing a massive change in the transcriptome. Additionally, we
were unable to show a higher degree of DC maturation on mRNA level in the spleen, which
confirms the phenotypical data.
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6.6 Mechanisms leading to colitis in DC-LMP1/CD40
animals
The permanent reduction of CD103+ DCs at steady state which was found in DC-LMP1/CD40
animals allowed us to investigate the influence of CD40 signaling on DCs on the induction of
tolerance and immunity in the GALT.
We did find an almost complete absence of induced Tregs while at the same time Th1
and T cells producing IL17 and IFN-𝛾 cells were increased. It has been shown previously
that CD103+ DCs have a superior capacity to induce Tregs and these cells were reduced in
frequency in our animals [48, 49]. Induced Tregs in turn are crucial to maintain tolerance in
Treg depleted mice, even after they have been reconstituted with nTregs [62]. One reason for
this might be a dramatic shift in the TCR repertoire found in iTregs induced in the GALT
when compared to nTregs. This distinct TCR specificity is shaped by interactions of Tregs
with commensal and food antigens [64], and may explain why even though we found normal
frequencies of nTregs in lamina propria of DC-LMP1/CD40 animals, these were unable to
prevent intestinal inflammation.
In another model, in which both CD103+ DC populations have been genetically deleted
[51], reduced numbers of Tregs in the lamina propria of the gut were found. The reduction
of colonic Tregs in this model was attributed to a reduced induction of CCR9+ Tregs in the
mLN. Contrary to the DC-LMP1/CD40 animals there was no development of autoimmunity
or a higher susceptibility towards DSS-induced colitis observed. This is probably due to
two reasons. First, the absence of Tregs induced in the mLN is not sufficient to cause colitis
without further stimulation and generation of effector T cells. Second, since both DC subsets,
that induce a Th1 or Th17 response [29, 30] are missing and these cells function as drivers of
intestinal inflammation, it is not surprising that the animals are not prone to T cell mediated
colitis. And although we found a reduction of CD103+ DCs, we were also able to show that
these cell do develop but they prematurely leave the lamina propria. Therefor, we do still
have DCs that are able to prime in DC-LMP1/CD40 animals.
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In contrast to the decrease in iTregs we found a strong increase in levels of IFN-𝛾- and
IFN-𝛾 IL17 double producing T cells in lamina propria while the frequency of IL17+ T cells
was unchanged. The role of Th17 cells has been shown to be a more protective one in most
models. For example, in a model of T cell transfer colitis animals actually developed more
severe disease when IL-17−/− T cells were injected [127]. And while this anti-inflammatory role
of Th17 cells holds also true in a DSS model [128], their role in a model of trinitrobenzesulfonic
acid(TNBS)-induced colitis is pro-inflammatory [128]. This varying role makes it difficult to
assess the role that the Th17 cells play in our model, but it seems more likely that IL-17
producing T cells are no drivers of the intestinal inflammation, since their frequency within
the CD4 compartment is unchanged.
The role of Th1 cells in intestinal inflammation is much clearer. They have been shown to
be one of the driving forces in intestinal inflammation [129]. This fits very well with the strong
increase of these cells that we see in the DC-LMP1/CD40 animals. In addition also the IL17
IFN-𝛾 double producing cells might play a role in pathology, since they are also increased
in all organs analyzed in this study as well as in the work of Ferdinand Simon (unpublished
results).
One open question is which cell type actually primes the T cell responses, when DCs of the
GALT are as strongly reduced. In contrast to the Batf3−/− x huLang-DTA mice, where both
CD103+ DCs subsets never develop [51], we can still find CD103+ DC in DC-LMP1/CD40 in
considerable numbers and the CD103− subsets was even increased in cell numbers. Our data
supports a model where after receiving the CD40-signal migration is induced to LN were they
finally die. This leads to a changed equilibrium which causes a reduction of CD103+ DCs but
not to their complete absence.
In addition, in DC-LMP1/CD40 animals CD103+ DCs also lost the potential to induce
peripheral Tregs. Whether the T cells in the end are primed by these functional changed
CD103+ DCs or whether other DC subsets perform the priming is not completely clear.
But Th1 and Th17 cells in the end play a central part in the development of intestinal
inflammation.
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6.7 Conclusion and outlook
In this study we analyzed the influence of CD40 signaling on DCs in different tissues and
its influence on tolerance and immunity. To this end, we employed a novel mouse model,
in which DCs directly receive a CD40 signal via expression of the LMP1/CD40 transgene
expressed under the control of CD11c-Cre.
We were able to show that CD40 stimulus alone is unable to completely mature DCs of
the spleen. Such maturation was neither observed on a phenotypical level, considering the
expression of costimulatory molecules and proinflammatory cytokines, nor on a functional
level, as shown by tolerance induction in a model of CD8 T cell transfer. This finding is in
line with previous works showing that CD40 signaling alone is not sufficient to fully mature
DCs.
DCs of GALT on the other hand show dramatical changes. We found that the CD40 signal
causes migration of CD103+ DCs from the lamina propria towards the mLN. DCs that arrived
at the mLN die there soon after. In DC-LMP1/CD40 animals the continuous CD40 signal
leads to constant migration of DCs and their subsequent death, which finally results in a shift
of the equilibrium leading to a strong reduction of CD103+ DCs in lamina propria and mLN.
However, not just the subset distribution but also the function of the DCs is changed by the
CD40 signal. DC-LMP1/CD40 animals completely lose their potential to induce peripheral
tolerance by iTreg generation, but instead may prime naïve T cells to become IFN-𝛾- and
IFN𝛾 IL-17-producing T cells. This breakdown of tolerance leads to the development of fatal
colitis.
This model nicely underlines the importance of a tight regulation of DC maturation to keep
up tolerance induction.
The functional change observed in DCs after CD40 stimulation actually represents an
attractive mechanism by which the activation of a T cell, and its subsequent upregulation of
CD40L, can transiently shut down the ability of DCs to induce tolerance and instead make
them mount an immune response. This would allow T cells, that already have been primed,
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to help amplify the immune response and thereby induce a quick, strong reaction against a
pathogen. This would also be self limiting, since DCs undergo apoptosis after antigen is no
longer found in the system and T cells would not be activated any more.
At this point it is unclear whether the activation and generation of CD40L+ T cells would
have a similar effect on DCs in vivo, but this theory can be proven by the transfer of either
preactivated T cells or by activating them in vivo. If CD40L on T cells shows similar effects
on DCs, it would also be of importance to test if this interaction is antigen dependent or if it
is facilitated just by CD40L-CD40 interaction.
Another important question that might be answered using the DC-LMP1/CD40 animals is,
if the cell that would have become an iTreg is the same cell which start to secrete IL-17 and
IFN-𝛾. To address this we will transfer OTII cells into DC-LMP1/CD40 animals and instead
of analyzing FoxP3 expression we will investigate if the cells are able to produce IFN-𝛾 or
any other proinflammatory cytokines, all of which should not be induced, when antigen is
administered orally. This would help elucidate the question of how plastic T cells are and
also show the influence of DCs on T cell fate decision.
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